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 In eukaryotic genomes ranging from plants to mammals, DNA methylation is a 
major epigenetic modification of DNA by adding a methyl group exclusively to cytosine 
residuals.  In mammalian genomes such as humans, these cytosine bases are usually 
followed by guanine [1].  Although it does not change the primary DNA sequence, this 
covalent modification plays critical roles in several regulatory processes and can impact 
gene activity in a heritable fashion [2, 3].  What is more important, DNA methylation is 
essential for mammalian embryonic development and aberrant DNA methylation is 
implicated in several human diseases, in particular in neuro-developmental syndromes 
(such as the fragile X and Rett syndromes) and cancer [4-6].  These biological 
significances disclose the importance of understanding genomic patterns and function 
role of DNA methylation in human, as a initial step to get to know the epigenotype and 
its manner in connecting the phenotype and genotype.   
 Two key papers back in 1975 independently suggested that methylation of CpG 
dinucleotides in vertebrates could be established de novo and inherited through somatic 
cell divisions by protein machineries of DNA methyltransferases that recognizes hemi-
methylated CpG palindromes [1, 7]. They also indicated that the methyl group could be 
recognized by DNA-binding proteins and that DNA methylation directly silences gene 
expression.  After almost four decades, several key points in these foundation papers are 
proved to be true. Take the mammalian genome for example, there are several findings 
indicating the epigenetic repression of gene expression by DNA methylation. These 
include: 1) X-chromosome inactivation, i.e. the inactivation of one of the two X 
 xii 
chromosomes in female somatic cells [8]; 2) Gene imprinting, the allelic-specific 
silencing occurring at imprinted genes, a group of mono-allelically expressed genes 
whose pattern are determined by the parental origin of the alleles. These genes are often 
found playing important roles in development, cellular proliferation and behavior [9, 10]; 
3) Suppress the proliferation of transposable elements and repeat elements of viral or 
retroviral origin [11]. In addition to these, many novel roles of DNA methylation have 
also been revealed. For example, intragenic methylation has been suggested playing 
major roles in regulating cell context-specific alternative promoters in gene bodies [12]. 
DNA methylation can also regulate alternative splicing by preventing CTCF, an 
evolutionarily conserved zinc-finger protein, binding to DNA [13]. By using the 
technique of fluorescence resonance energy transfer (FRET) and fluorescence 
polarization, DNA methylation has also been shown to increase nucleosome compaction 
through DNA-histone contacts [14]. What is more important, DNA methylation is 
essential for mammalian embryonic development and aberrant change of DNA 
methylation has been related to disease such as cancer [15, 16]. However, it is also 
notable there are several lines of evidence contradicting the relationship between DNA 
methylation and gene silencing. For example, comparison of DNA methylation levels in 
human genome on the active and inactive X chromosomes showed reduced methylation 
specifically over gene bodies on inactive X chromosomes [17, 18]. Not only in human, 
DNA methylation is found to be usually targeted to the transcription units of actively 
transcribed genes in invertebrate species [19-21]  These results prove that the function of 
DNA methylation is challenging to be unravel.  Besides, due to the development of 
sequencing technique, whole genome DNA methylation profiles have been detected in 
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diverse species. Comparing genomic patterns of DNA methylation shows considerable 
variation among taxa, especially between vertebrates and invertebrates.  However, even 
though extensive studies reveal the patterns and functions of DNA methylation in 
different species, in the mean time, they also highlight the limits to our understanding of 
this complex epigenetic system.  During my Ph.D., in order to perform in-depth studies of 
DNA methylation in diverse animals as a way to understand the complexity of DNA 
methylation and its functions,  I dedicated my efforts in investigating and analyzing the 
DNA methylation profiles in diverse species, ranging from insects to primates, including 
both model and non-model organisms. This dissertation, which constitutes an important 
part of my research, mainly focuses on the DNA methylation profile in primates 
including human and chimpanzee.  In general, I will use three chapters to elucidate my 
work in generating and interpreting the whole genome DNA methylation data.  Firstly, 
we generated nucleotide-resolution whole-genome methylation maps of the prefrontal 
cortex of multiple humans and chimpanzees, then comprehensive comparative studies for 
these DNA methylation maps have been performed, by integrating data on gene 
expression as well.  This work demonstrates that differential DNA methylation might be 
an important molecular mechanism driving gene-expression divergence between human 
and chimpanzee brains and also potentially contribute to the human-specific traits, such 
as evolution of disease vulnerabilities.  Secondly , we performed global analyses of CpG 
islands (CGIs) methylation across multiple methylomes of distinctive cellular origins in 
human.  The results from this work show that the human CpG islands can be distinctly 
classified into different clusters solely based upon the DNA methylation profiles, and 
these CpG islands clusters reflect their distinctive nature at many biological levels, 
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including both genomic characteristics and evolutionary features.  Moreover, these CpG 
islands clusters are non-randomly associated with several important biological 
phenomena and processes such as diseases, aging, and gene imprinting.  These new 
findings shed lights in deciphering the regulatory mechanisms of CpG islands in human 
health and diseases.  At last, by utilizing the DNA methylome from human sperm and 
genetic map generated from the International HapMap Consortium project,  we 
investigated the hypothesis suggesting a potential role of germ line DNA methylation in 
affecting  meiotic recombination, which is essential for successful meiosis and various 
evolutionary processes. Even thought the results imply that DNA methylation is a 
important factor affecting regional recombination rate, the strength of correlation 
between these two is not as strong as the previous report [22].  Besides, high-throughput 
analyses indicate that other epigenetic modifications, tri-methylation of histone 3 lysine 4 
and histone 3 lysine 27 are also global features at the recombination hotspots, and may 
interact with methylation to affect the recombination pattern simultaneously.  This work 
suggests epigenetic mechanisms as additional factors affecting recombination, which 
cannot be fully explained by the DNA sequence itself.  In summary, I hope the results 
from these work can expand our knowledge regarding the common and variable patterns 
of DNA methylation in different taxa, and shed light about the function role and its major 






 Back to 1958, Francis Crick, who is most noted as the co-discoverer of the 
structure of the DNA molecule, proposed the famous statement of the central dogma of 
molecular biology. This explanation of the flow of genetic information within a 
biological system, which was re-stated in a Nature paper published in 1970 [23], built the 
bridge for connecting the genotype and phenotype, through the sequential information-
carrying biopolymers in living organisms.  Since then, major efforts have been dedicated 
in the identification of genetic mutations, their use as biomarkers, and the understanding 
of their consequences on human health and well-being. Besides, many comparative 
studies have been performed between humans and non-human primates at the molecular 
level to reveal the genetic basis of human specializations [24, 25].  These works 
suggested that many of the key phenotypic differences among primates mainly result  
from alterations in the regulation of genes rather than in their sequences [26]. In general, 
most mechanism studies of the phenotype differences mainly stay at the genomic level by 
focusing on the regulatory region.  For example, DNA-binding transcription factors, 
which used to be thought as the most crucial determinants of gene expression patterns, 
can choose genes for transcriptional activation or repression by recognizing the sequence 
of DNA based in their promoter regions.  However, the genotype of transcription factors 
alone are not sufficient to define the spectrum of gene activity in view of the stable 
manner of the transcriptional potential of a genome during development [27].  In the past 
decade, there is an emerging interest in the possibility that changes at levels other than 
the genetic information could also have long-lasting consequences to the phenotype. 
These changes usually involve covalent modifications both in DNA and amino acids that 
constitute the N-terminal tails of histones.  These processes are less irrevocable than 
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genetic mutation and fall under the term 'epigenotype' that can stably maintain patterns of 
gene expression without changes in DNA sequence.  More and more evidence shows that 
epigenotype constitute a dynamic link between the genotype and the phenotype, both at 
the stage of establishment in different lineages of the embryo and the stage of somatic 
maintenance [28]. Modified by many different intrinsic and environmental factors, the 
resulting epigenotype can determine whether genes are maintained in a repressed or 
potentially active state, which in turn influences the phenotype both during development 
and postnatal life.  Besides, being heritable and less irrevocable than genetic mutation,  
epigenotype more likely stands for mark of developmental history since the genomic 
sequence of a differentiated cell is thought to be identical to the zygote from which it is 
descended. 
 As one of the most well-studied epigenotype, DNA methylation is best known as 
its significance in regulation of gene expression.  We hypothesize that changes of DNA 
methylation may play important roles in regulatory divergence between closely related 
species.  In the first chapter, by generating whole genome, single-CpG resolution DNA 
methylation profiles in prefrontal cortex of humans and chimpanzees through methyl-C-
seq method, we performed a comprehensive comparison of DNA methylation in these 
closely related species, and provided an unbiased view of the evolution of gene regulation 
in the context of conservation or changes in DNA methylation profiles. 
 
 
MATERIALS AND METHODS 
Generating Methyl-C-Seq Libraries 
 Regions of prefrontal cortex were dissected out of postmortem brains of three 
humans (Homo sapiens) and three chimpanzees (Pan troglodytes). Chimpanzee samples 
came from animals that died of natural causes or were euthanized for humane reasons at 
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the Yerkes National Primate Research Center, and all procedures involving these animals 
conformed to guidelines established by the Yerkes Institutional Animal Care and Use 
Committee. Human brain samples were obtained from the Maryland Brain and Tissue 
Bank from individuals who died of causes unrelated to neurological disorders. 
 Methyl-C-seq libraries for Illumina sequencing were custom constructed (Alpha 
Biolaboratory, Burlingame, CA) according to Lister et al. [29] with minor modifications. 
In brief, ~1 μg of genomic DNA was fragmented by sonication, end repaired, and ligated 
to custom-synthesized methylated adapters (Eurofins MWG Operon, Huntsville, AL) 
according to the manufacturer’s (Illumina, San Diego, CA) instructions. Adaptor-ligated 
libraries were subjected to two successive treatments of sodium bisulfite conversion with 
the EpiTect Bisulfite kit (QIAGEN, Valencia, CA) as outlined in the manufacturer’s 
instructions. Five to ten nanograms of bisulfite-converted libraries was PCR amplified 
with the following condition: 2.5 U of ExTaq DNA polymerase (Takara), 5 ml of 
10XExtaq reaction buffer, 25 mM dNTPs, 1 ml Primer 1.1, and 1 ml Primer 2.1 (50 ml 
final). The thermo cycle was as follows: 95 ºC for 3 min and then 14–16 cycles each of 
95 ºC for 30 s, 65 ºC for 30 s, and 72 ºC for 60 s. The enriched libraries were purified 
twice with the solid-phase reversible immobilization method with AMPure beads 
(Beckman Coulter, Brea, CA). We assessed the library quality by randomly subcloning 
and sequencing ~20–30 colonies to check for proper library construction and bisulfite 
conversion. The quality-controlled bisulfite-converted methyl-C-Seq libraries were then 
sequenced at the UC Berkeley Genome Center and Emory Genome Sequencing 
Laboratory with the Illumina Genome Analyzer II and the Illumina Hi-Seq, respectively. 
After quality control, the reads per lane ranged between 15 and 70 million reads. The 
average phred quality score for each read was 37. 
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Mapping and Annotation 
 We first converted all C’s to T’s both in the reads and in the reference genomes, 
and we then aligned the converted reads to the converted reference genomes by using the 
Bowtie algorithm [30].  The assembly versions of the reference genome we used for 
mapping are GRCh37/HG19 for humans and CGSC2.1/panTro2 for chimpanzees.  Total 
mapped reads accounted for 1.03 X 10
11
 (humans) and 9.80 X 10
10
 (chimpanzees) 
nucleotides, providing 34.33 and 32.63 species-level coverages for human and 
chimpanzee haploid genomes, respectively. 
 For comparative analyses of human and chimpanzee methylation profiles, we 
utilized the data sets from the Chimpanzee Sequencing and Analysis Consortium [31], 
consisting of 13,454 human-chimpanzee orthologous gene pairs.  The orthology of these 
gene alignments was considered unambiguous and covered the whole coding region.  On 
the basis of these ortholog RefSeq gene IDs, we downloaded the genomic coordinates 
from the UCSC genome browser.  Promoters were defined as regions 1.5 kb upstream 
and 0.5 kb downstream of the transcription start sites.  Gene bodies were defined as those 
encompassing the region from the transcription start site to the transcription end site. 
GeneTrail [32] and the DAVID tools [33] were used for the functional annotation 
enrichment and disease association tests. 
 
Identification of Methylated Cytosines Accounting for False-Positive Rates 
 We estimated the error rate (nonconversion rate plus sequencing error frequency), 
p, from the number of cytosine bases sequenced in reference cytosine positions in the 
unmethylated Lambda genome.  Error rates estimated from these were between 0.0013 
and 0.0017.  We controlled the number of false-positive methylcytosine calls below 0.1% 
of the total number of methylcytosines as follows: the minimum threshold number of 
cytosines sequenced at each reference cytosine position at which the position could be 
called as methylated is equal to (n * p) / (α(1 - p) + p), where n is the read depth for that 
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site, p is the error rate, and α is a predefined false-discovery value (0.001 for our case). 
Levels of DNA methylation were calculated by two methods.  First, in a false-discovery 
rate (FDR) method, each reference cytosine was examined and labeled as methylated or 
unmethylated according to the criterion that the number of false-positive methylcytosine 
calls should be below 0.1% (see above).  In the second method, we calculated the 
‘‘fractional methylation’’ values of each cytosine [21, 29]; these values are defined as the 
total number of ‘‘C’’ reads / (total number of ‘‘C’’ reads + total number of ‘‘T’’ reads). 
Results from these two methods were highly similar, and the results from the latter 
method are shown in the main text unless otherwise specified.  We discarded those sites 
with read depths of less than 3.  Results from before or after duplicates were removed 
with the Rmdup tool in the Samtools package were highly similar. 
 
Digital Gene-Expression Profiling Data 
 Frozen tissue samples from postmortem brains of six humans and six 
chimpanzees were used.  Human and chimpanzee individuals died of causes unrelated to 
neurological disorders.  Samples were dissected either from fresh tissue at the time of 
brain procurement or later on dry ice from frozen tissue pieces from the frontal pole 
region of the prefrontal cortex.  Total RNA was extracted with QIAGEN’s RNeasy or 
miRNeasy kits according to the manufacturer’s instructions.  All RNA samples were 
examined for quantity and quality by NanoDrop and Bioanalyzer (Agilent).  Sequencing 
libraries were generated from DpnII-digested poly-A enriched RNA according to the 
manufacturer’s (Illumina) instructions. BFAST [34] was used for aligning 20 bp reads to 
both the genome and RefSeq of the respective species.  We allowed up to one mismatch 
with the reference genome in any location within the read.  Only reads that aligned to one 
location in the genome were used for analysis.  Alignments to multiple isoforms of a gene 
were collapsed across gene symbol, and the maximum number of reads for a given 
isoform was used.  A gene was considered ‘‘present’’ if every individual of a species for 
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a given brain region had at least two reads aligned to the gene.  For differential 
expression analysis, a gene had to be present in at least one of the species being 
compared.  Reads were normalized with quantile normalization. 
 To examine whether there were any underlying batch effects in our data, we 
processed all samples from both species together.  Analysis of variance [35] of sample 
traits via univariate linear regression analysis with the first principal component as 
outcome revealed that species was the most significant sample covariate and was 
followed by individual and then age.  Technical variation sources, including postmortem 
interval, RNA batch, run batch, and library batch, were not significant, similar to a 
previous study [36].  Statistical significance of differentially expressed genes was 
determined with a Bayesian t test.  We also performed a two-sample permutation test 
between human and chimpanzee expression values and compared it to the p value from 
our original method. At the 5% significance level, approximately 92% of genes showed a 
concordant pattern between these two methods. For the inconsistent genes, most were 
significant from the permutation test and weakly significant from our original method. 
 
Comparative Human Methylome Analysis among Different Tissues 
 We compared the human prefrontal cortex (brain) methylome that had the highest 
mean read depth and lowest duplicate read count (Hs1570) to methylomes generated 
from human embryonic stem cells (ESCs) [37], human neonatal foreskin fibroblasts [37] 
and human peripheral-blood mononuclear cells (PBMCs) [38].  Methylation data from 
other tissues and cell lines were obtained from respective publications.  In brief, the ESCs 
were derived from aWA09 hESC line, and were cultured feeder free on Matrigel (Becton 
Dickinson) in StemPro medium (Lifetech), and were passaged with Accutase (Lifetech). 
The neonatal fibroblast cell lines were obtained from GlobalStem (newborn human 
foreskin fibroblasts, untreated) and were harvested for analysis at passage.  The human 
PBMCs were obtained from the same individual as in the YanHuang project, which is the 
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first finished diploid genome sequence of an Asian individual.  Methylome data on ESCs, 
neonatal fibroblasts, and PBMCs were downloaded from the Gene Expression Omnibus, 
and coordinates were converted from human genome build hg18 to hg19 with the UCSC 
liftover tool.  Bisulfite-converted sequence data were merged for all CG dinucleotides 
and CH dinucleotides (H = A, C, or T) that had at least three strand-specific reads in each 
of the four methylomes being compared.  Mean fractional methylation of annotated 
elements was calculated as the mean of fractional methylation values for each site within 




Genome-wide DNA-Methylation Patterns Reveal Extremely Heavily Methylated 
Brains 
 By sequencing the bisulfite-converted genomic DNA from prefrontal cortex 
samples, we generated whole genome, nucleotide-resolution DNA methylation maps 
(methylomes) from three humans and three chimpanzees.  Sequencing reads representing 
1.03  10
11
  and 9.80  10
10
 base pairs were generated from human and chimpanzee 
prefrontal cortex samples, respectively, corresponding to an average read depth of 11.4X 
and 10.9X per haploid genome.  Bisulfite conversion rates estimated from unmethylated 
lambda DNA controls show that the conversion rates are high enough to make sure our 
method faithfully captures patterns of genomic DNA methylation in these samples 
(Methods).  Prefrontal cortex methylation maps from both species revealed extremely 
heavy CpG methylation, where between 79.4% to 82.5% of CpGs are methylated.  In 
comparison, only minor fractions of non-CpG sites (1.3% to 2.2%) are methylated 
(Figure 1.1). Among the genomic regions, promoters and CpG islands are generally 
hypomethylated.  Transposable elements are the most heavily methylated in both species 
(Figure 1.1C), supporting the idea that DNA methylation suppresses proliferation of 
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transposons in these genomes [3].  DNA methylation levels across transcription units 
exhibit distinctive patterns similar to previous findings, where DNA methylation levels 
dip at the transcription start site, increase along the transcribed unit (gene body), and 
decrease again at the transcription termination site. 
 To gauge tissue-specific differences in levels of DNA methylation, we compared 
the methylation maps of the human prefrontal cortex to those from three other tissues, 
including ESCs, fibroblasts, and PBMCs.  These methylomes were all generated using 
similar methods, facilitating a direct comparison of overall levels of DNA methylation 
among these tissues [37, 38].  Our analysis reveals that the prefrontal cortex is the most 
heavily methylated of these four tissues (Figure 1.1A).  A high level of methylation of 
prefrontal cortex is consistent throughout different genomic regions and across different 





Figure 1.1. Differences in DNA-Methylation Levels among Human Tissues and 
Genomic Features (A) Proportional representation of genome-wide DNA-methylation 
levels for individual CG dinucleotides in the human prefrontal cortex (brain), ESCs, 
neonatal fibroblasts, and PBMCs.(B) Same analyses as in (A) but for CH dinucleotide 
context (H = A, T, or C). (C) Mean methylation levels in each tissue for gene promoters 
(CG context, n = 18,416; CH context, n ? 18,584), gene bodies (CG context, n = 18,477; 
CH context, n = 18,656), and transposable elements (CG context, n = 1,837,431; CH 
context, n = 2,989,765). Horizontal lines indicate global means of methylation levels for 
individual CG sites (main panel) or CH sites (inset). Error bars indicate 95% confidence 
intervals of the mean. 
 
 
Interspecies and Intraspecies Variation of Genome-wide Patterns of DNA 
Methylation 
 Genome-wide brain methylation maps of humans and chimpanzees exhibit 
intriguing intraspecific and interspecific variation (Figure 1.2).  Interestingly, prefrontal 
cortex samples from younger individuals in our study exhibit higher levels of DNA 
methylation in both species (Figure 1.2C and 1.2D).  For example, the chimpanzee 
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individuals are 24, 27, and 43 years of age. At the genome-wide level, the third (43-year-
old) individual exhibits slightly but significantly lower methylation than the other 
individuals. In human samples, a younger (31-year-old) individual is overall more 
heavily methylated than the other two individuals of ages 47 and 48 years.  However, 
given the small sample size, these results should be taken with caution and need to be 
validated in a study with a larger number of individuals spanning greater variation 
of ages. In term of the interspecies variations, the degree of DNA methylation is also 
slightly but significantly different between human and chimpanzee brains.  At the whole 
genome level, the average fractional methylation levels of CpG dinucleotides in the 
human and chimpanzee genomes are 80.9% (0.036%) and 82.1% (0.034%), 
respectively (Mann-Whitney test, P < 10
-15
).  In addition, species differences in DNA 
methylation levels are also apparent in both promoters and gene bodies of 12,533 human-
chimpanzee orthologs by using principal-component analyses (Figure 1.2A and 1.2B).  
Thus, our data suggest that human prefrontal cortex regions are generally less methylated 
than chimpanzee prefrontal cortex regions.  Our findings are at odds with a previous 
study that reported the opposite trend based upon a limited number of CpG sites [39].  
However, an analysis of the specific CpG sites included previously  revealed no 
difference between the two species in our data.  The difference might in part be due to the 
fact that the previous study used a low-resolution methylation array developed 
specifically for the human genome.  Moreover, our genome-wide results are consistent 
with another earlier study using HPLC, which suggested that human brains are generally 
less methylated than brains of other primates [40]. 
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Figure 1.2. Between- and Within-Species Variation of Genomic DNA Methylation 
in Human and Chimpanzee Prefrontal Cortex Regions.  Principal-component 
analyses of (A) promoters and (B) gene bodies of human-chimpanzee orthologs 
demonstrate that the patterns of DNA methylation are distinct between humans and 
chimpanzees. For promoters, the first principal component, which explains 46.1% of 
variation, distinguishes samples from human and chimpanzees. The second principal 
component, explaining 27.7% of total variation, separates two human samples from the 
third one. For gene bodies, the first principal component (explaining 42.8% of total 
variation) separates the third human from the rest, whereas the second principal 
component (explaining 22.6% of total variation) separates the human and chimpanzee 
brains. Hierarchical clustering analyses of (C) promoters and (D) gene bodies 
demonstrate that the overall levels of methylation are lower in human brains than in the 
chimpanzee brains. The youngest human individual (H3) exhibits the most distinctive 
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pattern of DNA methylation. The error bars indicate 95% confidence intervals of the 
mean. 
 
Distinctive Patterns of Promoter Methylation, Functional Enrichment, and Disease 
Association 
 Previous studies determined that DNA methylation in vertebrate promoters occurs 
in a discrete fashion—these promoters can be classified as hypermethylated and 
hypomethylated [41, 42].  In accordance with these studies, promoter DNA methylation 
in human and chimpanzee brains falls into distinct hypermethylated and hypomethylated 
classes (Figure 1.3A). In comparison, gene bodies are generally heavily methylated in the 
prefrontal cortex of both species (Figure 1.3B), which is expected under ‘‘global’’ 
patterns of genomic DNA methylation [41, 43].  Levels of DNA methylation in 
promoters and gene bodies are clearly lower in the human brain than in the chimpanzee 
brain(Figure 1.3A and 1.3B), a difference that is especially marked for promoters 
(Figures 1.3A and 1.3C), which on average exhibit 23% less methylation in humans than 
in chimpanzees. 
 To identify significantly differentially methylated promoters between human and 
chimpanzee brains, we performed the following tests. First, we performed a Fisher’s 
exact test by using the total numbers of methylated and unmethylated CpG sites in all 
samples and calculated adjusted p values by the FDR method for multiple testing [44, 
45].  Then, from the pool of significantly differentially methylated promoters obtained by 
this test, we further classified genes into those with hypermethylated (defined as 
fractional methylation levels > 0.8) or hypomethylated (fractional methylation levels < 
0.2) promoters (Figure 1.3). From these gene sets, we identified 474 genes whose 
promoters had ‘‘switched’’ between the hypermethylated and hypomethylated classes 
between the human and chimpanzee brains. In the majority (n = 468) of these promoters, 
human brains exhibit conspicuously lower levels of DNA methylation than do 
chimpanzee brains.  Interestingly, these genes are significantly enriched in molecular 
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functions such as protein binding and phosphotransferase activity (Table 1.1).  Moreover, 
they exhibit striking associations with several disorders, including neurological and 
psychological disorders and cancers. For example, genes whose variants are associated 
with autism are 3.5-fold enriched in this group of genes (although not significantly so 
because of the small number of genes (Table 1.2) ).  
 
Figure 1.3. Patterns of DNA Methylation in Genic Regions Influence Gene 
Expression. Density plots of (A) promoter and (B) gene-body DNA methylation from 
humans and chimpanzees. Promoter DNA methylation exhibits distinctive ‘‘bimodal’’ 
patterns.  In comparison, gene bodies of both species are heavily methylated (B).  DNA-
methylation-level differences, measured as the mean of human methylation levels minus 
the mean of chimpanzee methylation levels, show that promoters particularly exhibit 
lower levels of DNA methylation in the human brain than in the chimpanzee brain (C). In 
contrast, gene bodies show similar levels of DNA methylation between species (D). 
 
 The above-described method for identifying differentially methylated promoters 
is perhaps overly stringent.  Thus, we developed a second method, based on the relative 
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difference in promoter methylation, to identify differentially methylated promoters.  
Beginning with genes for which Fisher’s exact test using the false discovery method was 
significant, we first defined genes whose relative methylation levels have changed more 
than 50% (in other words, |(Chimp fractional methylation level - Human fractional 
methylation level)/(Chimp fractional methylation level + Human fractional methylation 
level)| is greater than 0.5).  We further restricted analysis to genes for which the absolute 
difference between the fractional methylation levels of humans and chimpanzees is 
greater than 0.2.  Using this method, we identified 1055 genes that are significantly less 
methylated in the human brains compared to the chimpanzee brains.  Analyses of these 
promoters again demonstrate patterns of functional enrichment and disease association 
similar to the above results. 
 
Table 1.1. Genes whose promoters are hypo-methylated in the human brains while 
hyper-methylated in the chimpanzee brains (n=468) are enriched in specific gene 
ontology (GO) terms. 
GO terms Accession P-value (FDR) 
cellular process GO:0009987 7.2e-05 
protein binding GO:0005515 1.8e-04 
cellular macromolecule metabolic 
process 
GO:0044260 1.9e-03 
cellular metabolic process GO:0044237 4.3e-03 






Table 1.2. Disease genes found in genes whose promoters are hypo-methylated in the 





neural tube defects 5 4.7 
PDGFRA(MIM 173490), 
SHMT1(MIM 182144), TYMS(MIM 
188350), DHFR(MIM 126060), 
CXCL6(MIM 138965) 
Autism 6 3.5 
GABRA2(MIM 137140) , 





alcohol dependence 4 5.0 GABRA2(MIM 137140), SLC6A4, 
GABRB1(MIM 137190), GABRG1 
Chemodependency 9 2.0 
GABRA2, GSTM1, SLC6A4, 
GABRB1, CLOCK, SCN5A(MIM 
600163), HOMER1(MIM 604798), 
GABRG1, CRTC1(MIM 607536) 
Cancer 27 1.3 
HPSE(MIM 604724), IRAK4(MIM 
606883), TES(MIM 606085), 
KIT(MIM 164920), RECQL(MIM 
600537), DHFR, KDR(MIM 
191306), IKZF3(MIM 606221), 
RAD51D(MIM 602954), 
CDK4(MIM 123829), CSF1(MIM 
120420), LIG3(MIM 600940), 
SUOX(MIM 606887), CXCL5(MIM 
600324), NRAS(MIM 164790), 
PDGFRA, GHR, RASSF8(MIM 
608231), TYMS(MIM 188350), 
POLR2B(MIM 180661), VDR(MIM 







DNA Methylation and Gene Expression in the Human and Chimpanzee Brains 
 A well-known consequence of DNA methylation is its effect on the regulation of 
gene expression [46].  Furthermore, differential expression of genes in humans and 
chimpanzees may drive lineage-specific patterns of evolution [25, 26, 47].  Given the 
profound influence of promoter DNA methylation on the regulation of gene expression, 
we asked whether changes of DNA methylation might underlie gene expression 
divergence between human and chimpanzee brains.  To address this question we 
integrated data on DNA methylation with data on gene expression from human and 
chimpanzee prefrontal cortex, generated using a next-generation sequencing method, 
digital gene expression profiling (DGEP, see Materials and Methods).   
 Levels of DNA methylation from promoters and gene bodies are each 
significantly negatively correlated with levels of gene expression (Spearman’s correlation 
coefficients range between -0.18 ~-0.24, as shown in Figure 1.4).  Several recent studies 
demonstrated a ‘bell shape’ relationship between gene expression and methylation, where 
the most heavily methylated gene bodies are often expressed at intermediate levels, and 
genes expressed at high and low levels are moderately methylated [20, 21].  However, in 
the prefrontal cortex samples, gene body methylation decreases roughly linearly with 
increasing levels of gene expression in both species (Figures 1.4B and 1.4D).  This 
finding is similar to a recent study where a linear and negative relationship between gene 
expression and DNA methylation in brain (both the occipital lobe and whole brain) was 
reported [46].  Thus the effect of gene body DNA methylation and gene expression is not 
universal across different tissues. 
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Figure 1.4. DNA methylation is negatively correlated with gene expression level in 
both promoters and gene bodies in prefrontal cortex.  Integrating levels of DNA 
methylation with levels of gene expression measured by digital gene expression profiling, 
we observe a negative correlation between human gene expression level and (A) human 
promoter methylation (Spearman’s correlation coefficient r = -0.24, P < 10
-15
) as well as 
(B) human gene body methylation (r = -0.18, P < 10
-15
).  The X-axis represents 
increasing levels of gene expression from left to right.  We also observe a negative 
correlation between chimpanzee gene expression level and (C) chimpanzee promoter 
methylation (r = -0.19, P < 10
-15
) as well as (D) chimpanzee gene body methylation (r = -




 Among the genes whose promoters are hypo-methylated in human but hyper-
methylated in chimpanzee brains, expression-level data are available for 273 genes.  A 
majority of these exhibit higher expression in human brains compared to chimpanzee 










































































brains (168 out of 273, P < 10
-4
, binomial test).  In comparison, none of the three genes 
whose promoters are hyper-methylated in humans compared to chimpanzees exhibit 
increased expression in humans.  When we restrict our analyses to genes with expression 
patterns that are significantly different between human and chimpanzee brains (Bayesian 
t-test, P < 0.05), the same pattern is observed: 41 out of 58 genes with significantly hypo-
methylated promoters in humans compared to chimpanzees exhibit higher levels of 
expression in human (P < 10
-4
).  Thus, differential promoter methylation between humans 
and chimpanzees manifest in different transcriptional levels (Figure 1.5A).  
 Again we find that many of these genes are implicated in neurological functions 
and disorders (Figure 1.5B).  For example, the insulin-like growth factor binding protein 
7 (IGFBP7 [MIM 602867]) gene regulates insulin-like growth factor availability and 
receptor binding, and is implicated in extinction of fear memories and neuro-genesis [48].  
Methylation levels of IGFBP7 promoters are dramatically different between the human 
and chimpanzee brains, and the expression of this gene exhibits a pattern concordant with 
the methylation pattern (Figure 1.5).  In another example, the sodium channel, voltage 
gated, type VIII alpha subunit (SCN8A [MIM 600702]) gene is implicated in wide-
ranging neurological and behavioral disorders and cognitive impairment, [49, 50] and is 
also hypo-methylated and significantly more strongly expressed in the human brain 
compared to chimpanzee brain (Figure 1.5).  
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Figure 1.5. Differences in promoter methylation associated with differences in gene 
expression between human and chimpanzee prefrontal cortex. (A) The proportion of 
genes with higher or lower expression values in human, as compared to chimpanzee, 
prefrontal cortex.  Each bar represents a class of genes based on the number of standard 
deviations from the mean ratio of methylation measures in human versus chimpanzee 
promoters in the prefrontal cortex. (B) Selected genes with hypo-methylated promoters in 
human, hyper-methylated promoters in chimpanzee, and significantly higher expression 
in human than chimpanzee.  Error bars, 95% confidence intervals of the mean (n = 6).  
Gamma-aminobutyric acid (GABA) A receptor, beta 1 (GABRB1) is involved in 
neurotransmission of the central nervous system.  Clock homolog (mouse) (CLOCK) 
encodes a transcription factor essential to the circadian rhythm.  Sodium channel, voltage 
gated, type VIII, alpha subunit (SCN8A) facilitates the generation of action potentials in 
neurons and other cells.  Growth hormone receptor (GHR) is integral to activating 
insulin-like growth factor production, leading to growth.  Insulin-like growth factor 
binding protein 7 (IGFBP7) regulates insulin-like growth factor availability and receptor 
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 Recent technical advances have enabled us to examine genomic variation of DNA 
methylation at the nucleotide-level [21, 29], revealing highly complex and dynamic 
tissue- and cell type- specific patterns of genomic DNA methylation.  In parallel, new 
functional studies are illuminating multi-faceted connections between DNA methylation 
and regulation of gene expression.  In addition to the well-known effect of promoter 
methylation in silencing gene expression, DNA methylation is also implicated in the 
regulation of alternative splicing [12] and the regulation of miRNA [51].  Thus, DNA 
methylation harbors a strong potential to influence regulatory divergence between 
species.   
 To elucidate the evolutionary significance of DNA methylation, in this study we 
examined the differences in genome-wide DNA methylation maps of human and 
chimpanzee brains and their consequences on gene expression divergence.  A few studies 
have previously investigated methylation difference between humans and non-human 
primates, but these studies either examined an extremely limited number of sites or used 
methods that are low-resolution and potentially biased due to underlying sequence 
differences [39, 40, 52].  In contrast, our study used the methyl-C seq method to resolve 
detailed patterns of genomic DNA methylation at individual nucleotide resolution.  
 One of the advantages of the methyl-C seq method is that it allows us to infer 
methylation frequencies of individual CpGs quantitatively.  Our DNA methylation maps 
reveal the prefrontal cortex to be by far the most heavily methylated tissue investigated so 
far (Figure 1.1).  Our results stand in contrast to the hypothesis that DNA methylation 
decreases in conjunction with cellular differentiation [37].  Rather, our study suggests 
that DNA methylation patterns undergo dynamic reprogramming in a tissue and cell-type 
specific manner.  The striking enrichment of DNA methylation in brains (Figure 1.1) also 
has important evolutionary implications.  It has been shown repeatedly that genes 
expressed in brains are, on average, the most evolutionarily constrained both in terms of 
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sequence evolution as well as gene expression patterns [25, 53].  The observation that the 
brain is the most heavily methylated among the tissues investigated so far suggests that 
DNA methylation may contribute to the constraints on sequence and expression 
evolution, possibly by suppressing gene expression noise [54].  Similarly, heavy 
methylation of transposable elements in brain may indicate particularly strong silencing 
of transposable elements [3].  
 We observed intriguing within- and between-species variation of DNA 
methylation in the brains of humans and chimpanzees.  In both species, samples from 
younger individuals (31 versus 47 and 48 in humans, 24 and 27 versus 43 in 
chimpanzees) tend to exhibit heavier DNA methylation compared to older individuals 
(Figure 1.2).  Previous studies, investigating limited numbers of CpG sites or genes, 
reported both increases and decreases of DNA methylation with aging [55-59].  Our data, 
while representing the first genome-wide analyses of CpG sites, consist of only three 
individuals per species with relatively similar ages, thus should be taken with caution.  
Nevertheless, it is interesting to note that studies analyzing CpG islands have generally 
reported increased DNA methylation with increasing age, while some studies reported 
that CpGs that are not in CpG island context tend to lose DNA methylation with aging 
[58].  
 The overall patterns of DNA methylation differ between human and chimpanzee 
brains: notably the chimpanzee brains exhibited higher DNA methylation levels 
compared to human brains.  Our results are in accord with an earlier study that used high 
performance liquid chromatography (HPLC) to quantify the levels of methylcytosines 
from the brains of human, macaque, African green monkey and squirrel monkey and 
showed that the human brain exhibited the least amount of methylcytosines among these 
species [40].  However, the fact that DNA methylation varies with age, and that it is not 
straightforward to ‘match’ ages between human and chimpanzee samples, cautions 
drawing a general conclusion from the limited number of samples used in this study.  
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Nevertheless, it is notable that the species-level difference between humans and 
chimpanzees is the most pronounced in promoters (Figure 1.3).  Given the observation 
that human promoters are generally hypo-methylated compared to chimpanzee 
promoters, the increase of gene expression in the human brains compared to the brains of 
chimpanzees [60-62] may be partially mediated by an overall decrease of DNA 
methylation, particularly in promoters.  Future analyses of outgroup primates, such as 
Old World monkeys, will help elucidate lineage-specific changes in these epigenetic 
modifications.  
 Furthermore, promoters that are significantly differentially methylated between 
the brains of humans and chimpanzees (most of which are hypo-methylated in the human 
brains compared to the chimpanzee brains) are enriched in several functional categories, 
including protein binding and cellular metabolic processes.  Strikingly, the list of genes 
harboring differentially methylated promoters includes disproportionately high numbers 
of those associated with human diseases (Table 1.2).  In particular, this list of disease 
includes neuro-developmental and psychological disorders, such as neural tube defects, 
autism, and alcohol and other chemical dependencies.  Interestingly, they represent a 
characteristic set of diseases to which modern humans are particularly susceptible [63].  
This suggests that methylation differences between human and chimpanzee brains may 
have significant functional consequences and potentially bear relevance to the evolution 
of human specific disease vulnerabilities.  Given that DNA methylation functions as a 
modulator of environmental signals to cellular regulatory machineries [64, 65], 
comparative epigenomic studies like ours will allow us to better understand both the 
genetic and environmental contributions to species differences.  Thus, our results 
highlight the utility of comparative studies in identifying key epigenomic modifications 






 Thirty-eight years ago, two independent studies proposed that cytosine DNA 
methylation in eukaryotes could act as a stably inherited modification affecting gene 
regulation and cellular differentiation [1, 7].  Since then, intense effort has expanded our 
understanding of diverse aspects of DNA methylation in higher eukaryotic organisms, 
especially human.  Now it is well known that the degree of DNA methylation in the 
human genome is extensive: most of CpG dinucleotides in the human genome are 
methylated in most tissues and developmental stages, which is referred to as "global 
DNA methylation" [66].  However, some genomic regions, e.g., CpG islands, exhibit 
prominent exceptions to this pattern [67].  Originally, CpG islands were defined as 
clusters of hypo-methylated CpG dinucleotides in the heavily methylated mammalian 
genomes [68, 69].  In order to get a comprehensive map of CpG islands among genomic 
sequences, several computational algorithms have been developed [70, 71].  A key 
feature of these computational algorithms is a metric to quantify the observed frequency 
of CpG dinucleotides normalized by the G+C content, commonly referred to as ‘CpG 
O/E’.  Genomic regions exhibiting particularly CpG O/E, among other characteristics, are 
generally considered as good candidates of CpG islands. 
 Accompanied with the improvement of CpG islands definition, numerous studies 
also indicated the critical importance of CpG islands in regulatory and developmental 
processes. For example, many CpG islands co-localize with promoters [72-74].  They are 
often characterized by transcriptionally permissive chromatin states [75, 76], and 
frequently overlap with enhancers and other regulatory elements [77-80].   
 The regulatory effects of CpG islands often critically rest on the ‘correct’ (or the 
lack of) DNA methylation. For example, even though CpG islands are generally 
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characterized by their unmethylated status, some CpG islands undergo DNA methylation, 
often in tissue- or developmental stage-specific manner.  What is more important, 
aberrant methylation at some CpG islands is implicated with diseases, in particular, 
cancer [81, 82].  Therefore, understanding the full extent of variation of DNA 
methylation in CpG islands and its functional consequences has tremendous implications 
for advancing our knowledge of molecular mechanisms of regulation and development. 
 Moreover, recent studies begin to unfold intriguing functional heterogeneity 
among CpG islands.  For example, long CpG islands and short CpG islands exhibit 
different regulatory activities such as gene expression complexity [83] as well as 
nucleosome depletion patterns [84].  A recent evolutionary study has determined that 
while the majority of CpG islands may actively avoid DNA methylation, some CpG 
islands are likely to maintain high CpG contents via methylation-independent processes 
such as biased gene conversion [85].  These findings begin to shed lights on the potential 
diversity among CpG islands.  At the same time, they highlight many unanswered, 
critical questions: for example, do the computationally predicted lists of CpG islands 
capture the true epigenomic and functional complexity of CpG islands?  Do all CpG 
islands exhibit tissue and developmental stage specific variation of DNA methylation?  
Alternatively, is there a group of CpG islands that tend to exhibit variable patterns of 
DNA methylation?  How are these variations of DNA methylation related to regulatory 
functions of CpG islands?  Do methylation profiles of CpG islands differ according to 
their evolutionary mechanisms? In chapter 2, I will describe my investigation of these 
pressing questions by analyzing whole-genome, nucleotide resolution methylation maps 
from multiple methylomes of distinctive origins. 
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MATERIALS AND METHODS 
Whole Genome Methylomes 
 We used whole genome, nucleotide-resolution DNA methylation maps 
(methylomes).  We focused on analyzing normal tissues or primarily tissue derived cell 
lines, rather than differentiated cell lines or cancer genomes.  Primary data consists of 
methylomes generated from human embryonic stem cells (ESCs) [86], human neonatal 
foreskin fibroblasts [86], human peripheral-blood mononuclear cells (PBMCs) [87], 
prefrontal cortex of human brain [88] and human sperms [89].  These methylomes were 
all generated with next-generation bisulfite sequencing technology and have similar 
number of mapped CpG sites, facilitating a direct comparison of CpG island methylation 
among tissues.  As a comparison, we contrasted the whole genome methylation data from 
the prefrontal cortex to those generated via the reduced representation bisulfite 
sequencing methods as a part of the ENCODE project from the " BC_Brain_H11058N " 
cell line.  Comparison of these data sets demonstrates that the whole genome methylation 
sequencing provides a superior coverage of CpG islands (Figure 2.1).  We extended our 
analyses to three additional methylomes: placenta, kidney and cerebellum [90].  These 






Figure 2.1. CpG island coverages. We compared the coverages of CpG sites in CpG 
islands between the data generated by the ENCODE project to the data from 
comprehensive methyl C seq method.   The ENCODE project used a modified version of 
Reduced Representation Bisulfite Sequencing.  These profiles present an excellent 
overview of genomic DNA methylation variation.  However, to obtain a comprehensive 
variation of DNA methylation of CpG islands, the methylC seq data clearly outperforms 
this data, as shown below.  We compared the brain methyl seq data to ENCODE data 
from the BC_Brain_H11058N cell line. The distribution of CpG sites coverage within 
CpG islands is shown for the ENCODE data (black) and for the methylC-seq data (red).  
Coverage is calculated as number of mapped CpGs divided by number of total CpGs in 




Table 2.1. Human DNA methylome datasets used in chapter 2  




























Sperm M GSE30340 16X 28.2 
RMAPBS 
(98.7%) 
Placenta F GSE39775 1.6X 23.9 
BS-seeker 
(99.3%) 
Cerebellum M GSE39775 0.3X 8.3 
BS-seeker 
(99.3%) 
Kidney M GSE39775 0.5X 8.9 
BS-seeker 
(99.3%) 
1: The mapping procedures for all tissues used a "reduced"’ three-letter alphabet 
comprising A, G, and T, where all C’s were converted to T’s both in the reads and in the 
reference genome to accommodate the conversion of unmethylated cytosines to thymines 
by bisulfite conversion. Besides, all the datasets contain the quality control steps such as 
the standard Illumina sequencing pipeline for base calling and quality filtering, all the 
redundant reads were removed before the alignment to the reference genome.  
2: The efficiency is referred as the conversion rate of the unmethylated CpGs from the 
bisulfite treatment. 
 
CpG Island Annotation and Methylation 
 The annotations of the CpG island used in this study were downloaded from 
UCSC Genome Browser [91].  These CpG islands are characterized as at least 200 bps in 
length, GC content of 50% or greater, and a CpG frequency (observed/expected; [o/e]) of 
0.6 and exclusive of repetitive sequences.  To estimate the methylation level for each 
CpG island, we calculated the mean fractional methylation value for all the mapped 
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cytosines within the CpG island.  For each mapped cytosine, the fractional methylation 
value was calculated as: total number of "C" reads / (total number of "C" reads + total 
number of "T" reads), following previous studies [92].  To identify differentially 
methylated CpG islands between oocyte and sperm in mouse, we extracted the location of 
these CpG islands from, and used the UCSC liftOver tools to convert the coordinates 
from genome build mm10 to hg18. 
 Genomic control regions (non-CpG island controls) are obtained using the 
following procedures.  We first removed all the CpG islands from the whole genome and 
then randomly sampled genomic regions with the length distribution identical to the list 
of CpG islands.  Methylation levels of these control regions are calculated the same way 
as CpG islands.  We repeated this procedure 1000 times. We performed this sampling 
with and without removing CpG islands. The results from both analyses are consistent, 
and in this dissertation we present results obtained without removing CpG islands. 
 
Identification of High Methylation Variability Regions 
 We identified highly differentially methylated regions (‘High Methylation 
Variability Regions, HMVRs’) from the comparison of the five methylomes using a 
sliding window approach.  First, we calculated coefficient of variation of DNA 
methylation (standard deviation/mean) of all CpG sites in the human genome, using the 
comprehensive methylation information of all nucleotides in the five methylomes.  Then, 
we identified individual CpG sites that exhibit high variation using a cutoff value of C.V. 
= 1 (this roughly corresponds to >2.4SD, and top 0.5% quantile of the whole CpG sites).  
A total of 0.69 million CpGs out of 21.7 millions examined CpGs sufficed this criterion.  
Then, using a 2-kb sliding window with a 200 bps step size of increment, we extended 
the window until each window contained less than 50% of HMV CpG sites.  HMVRs are 
then defined as genomic regions that include 5 or more HMV CpG sites.  We also tried 
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combinations of different parameters to identify HMVRs: our results did not change 
qualitatively. 
 
Hierarchical Clustering Analyses 
 Clustering of CpG islands of the five tissues methylome data was performed using 
a function called 'clustergram' in MATLAB.  It employs hierarchical clustering with a 
Euclidean distance metric to first cluster the tissues and then cluster the CpG islands.  
Ward linkage was employed to generate both dendograms. 
 
Analyses of Gene Expression 
 Gene expression data from 6 human tissues (prefrontal cortex, cerebellum, heart, 
kidney, liver and testis) were based upon whole genome RNA sequencing [93].  These 
data were aligned to the respective genome sequences by the TopHat program. The 
expression levels were normalized by mean per-base read coverage with unambiguously 
mapping reads.  The samples measured for the same tissue were averaged to represent the 
expression level for that specific tissue.  The second data set is based upon Affymetrix 
human genome U133A array which were downloaded from Gene AtlasV2 (GSE1133), 
where the expression level is standardized by MAS5.0 algorithm [94].  We removed 
disease tissues and used only normal tissues.  Based upon these expression values, the 
"tissue specificity index" [95] is defined by incorporating information on the maximum 
expression level among the tissues in each data set, as follows:  
 
where n is the number of tissues analyzed, Ej the expression level of the gene in the 
jth tissue and Emax the maximum expression level of the gene across the 6 tissues. The 
higher the tissue specificity index of a gene, the more the tissue-specific its expression 
pattern is. To define the association of the genes to certain CpG island, we first extended 
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the genes at both 5' and 3' end by 1500 bp, and we called that the gene is associated with 
certain CpG island if there is any overlap between the extended region and the CpG 
island.  
 To examine overlaps between CpG islands and transcription factor binding sites, 
we downloaded the location of transcription factor binding sites conserved in the 
human/mouse/rat alignment from UCSC genome browser.  A binding site is considered 
conserved across the alignment based upon the score threshold computed with the 
Transfac Matrix Database (v7.0).  Transcription factor binding sites that are completely 
located within the CpG islands are counted for each CpG island. 
 
Evolutionary Substitution Rates of CpG Islands 
 We used Cohen et al. [85]’s evolutionary data downloaded from the Tanay lab 
website (http://compgenomics.weizmann.ac.il/tanay).  The data consist of a list of bigWig 
tracks containing observed and expected evolutionary dynamics in 50bp resolution, 
smoothed over 2kb windows.  We converted the bigWig encrypted files to bedGraph files 
using the UCSC utility bigWigToBedGraph.  We then computed the weighted average of 
observed and expected rates for each CpG island region using custom perl scripts. 
 
Discriminant and Classification Analyses 
 We performed linear discriminant analyses using the "lda" function from the 
package of "MASS" in R.  We also performed support vector machine analyses using the 
"ksvm" function from the package of "kernlab" in R.  For both analyses, 20% of the 
whole data were randomly selected as the training data set.  After training the model, the 
predictions were made for the test data set and the accuracy was evaluated based upon the 





Patterns of CpG Islands DNA Methylation in Whole Genome Methylomes 
 We analyzed comprehensive whole genome nucleotide-resolution DNA 
methylation maps (referred to as ‘methylomes’ henceforth) from eight distinctive human 
samples (prefrontal cortex of brain, embryonic stem cells, neonatal foreskin fibroblasts, 
peripheral-blood mononuclear cells, sperms, placenta, cerebellum, and kidney: Table 
2.1).  We did not include methylomes originating from induced pluripotent stem cells 
[96], as the epigenetic patterns of these cells may differ from those from normal somatic 
cells.  Among these methylomes, five (prefrontal cortex of brain, embryonic stem cells, 
neonatal foreskin fibroblasts, peripheral-blood mononuclear cells, sperms) methylomes 
offer similarly comprehensive, high coverage information across the whole genome 
(Table 2.1).  Including data from all eight methylomes reduced the number of examined 
CpG sites dramatically (~8 fold: Table 2.1).  Nevertheless, the results of the analyses of 
these five methylomes and the total eight methylomes are highly similar, and for the rest 
of the results in this study,  only results from the five comprehensive methylomes are 
presented. 
 We calculated methylome-specific DNA methylation levels of CpGs across the 
whole genome (Materials and Methods).  From the five whole genome methylomes, we 
annotated methylome-specific DNA methylation of 26.7 million CpG dinucleotides, 
corresponding to 88.7% of all CpG dinucleotides in the human genome.  Using this 
method, we determined methylome-specific levels of DNA methylation for 25,131 CpG 
islands, encompassing 89% of all annotated CpG islands in the UCSC genome browser.  
Comparisons to methylation data from other methods indicate that the data we used offer 
superior resolution for examining the detailed variation of DNA methylation in CpG 
islands (Figure 2.1).   
 As expected, CpG islands exhibit significantly reduced methylation compared to 
the genomic background (Mann-Whitney test, P < 10
-15
, Figure 2.2A).  Notably, CpG 
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islands in sperms are the least methylated among the 5 methylomes, even though the 
sperms themselves are not the least methylated among those (Figure 2.2A).  This is not 
due to inactivation of the X chromosome during spermatogenesis: this pattern persists 
even when the data from the X chromosome is removed.  When examined individually, 
the majority of CpG islands are hypo-methylated (methylation level <20%).  However, 
substantial numbers of CpG islands are hyper-methylated (methylation level >80%) 
(Figure 2.2B).  The percentages of hyper-methylated CpG islands range between 15% in 
sperm, to 23% in embryonic stem cells.  Interestingly, we discovered a strong negative 
correlation between CpG island lengths and the average methylation levels across the 
methylomes: longer CpG islands tend to be more markedly hypo-methylated (Spearman’s 





Figure 2.2. Overview of DNA methylation at CpG islands across tissues (A) Mean methylation levels of CpG sites in genomic 
background (blue bars) versus those in CpG island context (red bars). (B) Distribution of CpG islands that are lowly methylated 
(<20% mean fractional methylation levels), intermediately methylated (20%~80% mean fractional methylation levels) and highly 
methylated (>80% mean fractional methylation levels) across the five methylomes examined.  (C) Correlation of CpG island length 
and methylation level.  A regression of log transformed CpG island length versus log transformed average methylation level from 5 
human methylomes, divided into 40 bins, shows a high negative correlation (R
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CpG Islands Mark Highly Variable DNA Methylation Regions 
 Having demonstrated the overall hypo-methylation of CpG islands and hyper-
methylation of some CpG islands, we then examined DNA methylation variability of 
CpG islands.  Several studies have identified differentially methylated CpG dinucleotides 
and genomic regions among different tissues and cell types, many of them (but not all) 
included CpG islands [97-103].  Analyses of whole genome methylation maps provide a 
unique opportunity to identify genomic regions whose methylation levels vary between 
different tissues.  With the methylation level of individual CpGs present in 5 
methylomes, we examined variability of DNA methylation.  For this purpose, we used 
the coefficient of variation (CV: standard deviation divided by mean), which is a 
commonly used metric to compare the level of variability of biological data [104-106].  
Then we developed a sliding window approach to define ‘high methylation variability 
regions’ (HMVR, Materials and Method) of the human genome.  We identified a total of 
17,045 HMVRs, spanning 51.2 million bps and containing 0.70 million CpG 
dinucleotides.  Remarkably, CpG islands are highly significantly over-represented in 
these HMVRs.  Under a criterion of over 80% overlap, 12,683 CpG islands overlap with 
these HMVRs.  In comparison, the expected number of CpG islands in HMVRs is only 
483 (P < 10
-20
, Fisher’s exact test).  Similar results were obtained when different criteria 
were used to identify HMVRs.  Thus, even though generally hypo-methylated, CpG 
islands in fact exhibit tremendous level of DNA methylation variation across 
methylomes.  This pattern is apparent when we compare the variability of methylation 
levels of CpG islands to those of ‘control’ regions (Figure 2.3). 
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Figure 2.3. Comparisons DNA methylation level and variation between CpG islands 
and control region (A) CpG islands (blue bars) exhibit lower level of DNA methylation 
compared to genomic background (red bars). (B) Levels of DNA methylation variation, 




Distinctive Clusters of Human CpG Islands Based On DNA Methylation Patterns 
 Having established that CpG islands exhibit highly variable DNA methylation 
across the whole genome methylomes, we investigated patterns of DNA methylation 
variation more deeply.  We employed a hierarchical clustering approach (Materials and 
Methods) to group CpG islands according to their similarities of DNA methylation across 
the five methylomes.  The resulting ‘heat map’ of DNA methylation variation across CpG 
islands reveals several intriguing patterns (Figure 2.4).  Interestingly, the clustering 
pattern of the methylomes does not reflect the gender or developmental stages of the 
original tissue or cell samples: among the five methylomes, only the ESC has female 
origin.  ESC methylome clusters with other methylomes of male origin.  It is also notable 
that the ESC methylome is closer to those of highly differentiated cell methylomes.  On 
the other hand, sperm methylome is the most distinct among the five methylomes, which 
is consistent with our previous results indicating that sperm CpG islands are the least 
methylated among the five methylomes.  This pattern highlights epigenetic differences 
between germ lines and somatic tissues, and regulatory effects of DNA methylation on 



































patterns of DNA methylation from that of other tissues, highlighting the unique 
developmental potential of these cells.   
 Strikingly, CpG islands form several distinct clusters according to their 
methylome-specific DNA methylation patterns (Figure 2.4).  As expected, many CpG 
islands exhibit sparse levels of DNA methylation in all five methylomes.  These are 
designated as ‘Cluster I’ (Figure 2.4A).  Note that many CpG islands in this cluster still 
exhibit high levels of methylation variability (Figure 2.4A).  The rest of CpG islands are 
differentially methylated in different methylomes.  Among these, approximately half of 
CpG islands are notably hypo-methylated in sperms, yet exhibit highly variable patterns 
of methylation in somatic tissues and embryonic stem cells (cluster II, Figure 2.4A).  The 
remaining CpG islands tend to be heavily methylated in sperms and methylated in some 
somatic tissues and embryonic stem cells (cluster III in Figure 2.4A).  We can further 
divide the clusters II and III to sub-clusters, which exhibit distinctive variability of DNA 
methylation.  For example, cluster II can be subdivided into those that exhibit sparse 
methylation in sperm but relatively heavy methylation in somatic cells (sub-cluster IIa), 
and those exhibiting sparse methylation in sperm and highly variable and often sparse 
patterns of methylation in somatic cells (sub-cluster IIb) (Figure 2.4B). Cluster III 
includes a distinctive subcluster of CpG islands that exhibit heavy methylation in all 
tissues (sub-cluster IIIa), compared to those that show variably methylated across tissues 
(sub-cluster IIIb, Figure 2.4C).  
 To determine whether the observed pattern is applicable to a larger number of 
tissues and cell types, we incorporated nucleotide-resolution DNA methylation maps 
from additional three methylomes generated from placenta, cerebellum and kidney 
(Materials and Methods).  These additional methylomes consist of markedly lower 
sequencing coverage and/or few CpG sites compared to the five comprehensive 
methylomes.  Despite such difference in sequence coverage and quantity, clustering 
analyses using these eight methylomes clearly demonstrate distinctive CpG islands 
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clusters that are highly similar to the above results (Figure 2.5).  Together, these results 
indicate that human CpG islands can be clearly classified into several groups according to 




Figure 2.4. Hierarchical Clustering of CpG islands according to their methylation levels in 5 human methylomes.  The bar on 
top left represents relative methylation levels, where "Heavy" stands for the methylation level of 100% while "Sparse" stands for no 
methylation.  (A) Three distinctive clusters are indicated  (B) Some CpG islands are hypo-methylated in the sperm methylome, but 
hyper-methylated in other methylomes (IIa, n=2357) or exhibit variable levels of hyper-methylation in other methylomes (IIb, 
n=1751).  (C) Some CpG islands are generally hyper-methylated in all methylomes (IIIa, n=3885) or exhibit some level of tissue-





Figure 2.5. Hierarchical Clustering of CpG islands according to their methylation levels in 8 human methylomes.  The bar on 
the top left represents relative methylation levels. Three distinctive clusters are indicated. Cluster I , II, II consists of 11231, 1437 and 
2283 CpG islands respectively. Individual cluster consistency percentage with 5-tissues clustering is indicated in the parenthesis 




Epigenomically Identified CpG Island Clusters Are Genomically Distinctive  
 Having identified distinctive patterns of DNA methylation variability across CpG 
islands, we examined whether these CpG islands clusters exhibit different characteristics. 
Intriguingly, we find that these clusters, which have been identified solely based upon 
patterns of DNA methylation variation, differ significantly in several genomic 
characteristics.  The cluster I CpG islands tend to be the longest, which is consistent with 
our observation that longer CpG islands tend to be less methylated.  They also contain the 
most G and C nucleotides and exhibit the highest CpG O/Es, and harbor the largest 
numbers of CpG dinucleotides, compared to those in other clusters (Figure 2.6A-C).  On 
the other hand, cluster III CpG islands are distinctively shorter than those in other 
clusters, as well as exhibiting lower GC contents and lower CpG O/Es.  Notably, these 
CpG islands consist of strikingly fewer numbers of CpG dinucleotides compared to those 
in other clusters (Figure 2.6D).  In comparison, CpG islands in the cluster II generally 
exhibit genomic characteristics that are intermediate of the other two clusters.  These 
differences are not due to the bias in mapping: CpG islands in the three clusters show 
similarly high mapping coverages.  Autosomal and X-linked CpG islands also exhibit 
heterogeneous distribution: CpG islands on the X chromosome are slightly yet 
significantly enriched in cluster I, while deficient in cluster III (Table 2.2).  These 
clusters also exhibit enrichment of distinctive genomic regions: cluster I consist of largely 
promoter-associated CpG islands, while clusters II and III include large numbers of 
intragenic and intergenic CpG islands (Figure 2.6E).  The observation that CpG islands in 
clusters II and III tend to exhibit highly methylome-specific patterns of DNA methylation 
is thus consistent with the idea that intragenic and intergenic CpG sites are highly 
variably methylated and exhibit tissue- specific DNA methylation [110].   
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Figure 2.6. Contrasting genomic features of the three CpG island clusters. 
Significant differences are found in (A) lengths, (B) GC content, (C) CpG O/E, and (D) 
number of CpG dinucleotides among the three clusters. (E) Occurrence of promoter-, 
intragenic- and intergenic- CpG islands across the three CpG islands clusters.  
Significance level ***: P < 10
-6



























































































































Table 2.2.  The numbers of X-linked CpG islands compared to all CpG islands.  X-linked 
CpG islands are over-represented in the cluster I and under-represented in cluster III.   
 Cluster I Cluster II Cluster III  
X-linked CpG 
islands 
366 76 27  
All CpG islands 16183 4032 4447  




DNA Methylation Variation Supports Evolutionary Diversity of CpG Islands  
 As genomic features are determined by evolutionary processes, we sought to 
determine underlying evolutionary mechanisms of distinctive CpG island clusters.  For 
this we used recently available evolutionary classification of CpG islands by Cohen et al. 
[85].  This study used parameter-rich evolutionary models to infer evolutionary forces 
underlying the evolution and maintenance of CpG islands in primate genomes.  Because 
methylated cytosines frequently mutate to thymines, DNA methylation in effect depletes 
CpG dinucleotides [111, 112].  It was originally proposed that CpG islands manage to 
maintain high CpG contents against this mutational pressure of DNA methylation by 
avoiding DNA methylation [67-69].  Indeed, Cohen et al. identified many CpG islands 
with evolutionary signatures of hypo-methylation.  They named these CpG islands as 
‘hypo-deamination’ CpG islands.  On the other hand, their analyses revealed that some 
CpG islands maintain CpG contents via biased gene conversion process (referred to as 
‘biased gene conversion’ CpG islands).  They also identified ‘pseudo’ CpG islands, 
which are genomic regions that happen to harbor large numbers of CpG dinucleotides by 
chance, and expected to lose their CpG contents through evolution.   
 Our data on high resolution DNA methylation variation of CpG islands provide a 
novel way to test some of the predictions and implications of these evolutionary analyses.  
First, ‘hypo-deaminated’ CpG islands should exhibit hypo-methylation in germlines.  We 
found that cluster I CpG islands, which are hypo-methylated in all five methylomes, are 
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overrepresented in ‘hypo-deamination’ groups (Figure 2.7B).  The fact that they are also 
hypo-methylated across somatic tissues (in addition to in sperms) indicates that 
evolutionary pressures for hypo-methylation of these CpG islands may share some of the 
same underlying mechanisms with somatic hypo-methylation.  On the other hand, we 
detected a strong influence of biased gene conversion in CpG islands in clusters II and III 
(Figures 2.7C and 2.7D).  Because biased gene conversion process preferentially fixes C 
and G nucleotides, they can generate CpG dinucleotides, and consequently, counter-
balance the mutational depletion of CpGs.  CpG islands in the cluster III also include 
disproportionately large numbers of ‘pseudo’ CpG islands (9%, significantly higher than 
0 and 2% in CpG island clusters I and II).  
 
Figure 2.7. Evolutionary Diversity of 3 CpG Island Clusters. Frequencies of hypo-
deaminated, biased gene conversion (BGC), and pseudo CpG islands in (A) all CpG 
islands, (B) cluster I, (C) cluster II and (D) cluster III. 
(A) 















Cluster I Cluster II Cluster III 
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Functional Diversity of CpG Islands Reflected in DNA Methylation Variation 
 We have so far demonstrated that epigenetic variability of CpG islands represents 
distinctive clusters, and is tightly linked to genomic and evolutionary variability in the 
human genome.  We posit that these distinctive CpG clusters further indicate regulatory 
diversity among CpG islands.  Specifically we hypothesize that the regulatory functions 
of cluster I CpG islands are tightly linked to their hypo-methylation status.  In contrast 
the regulatory effects of CpG islands in the clusters II and III may critically rest on their 
cell- and tissue-specific hypo- and hyper-methylation.   
 To test these hypotheses we performed several analyses to examine functional 
diversity among CpG island clusters in the human genome.  First, we performed gene 
ontology analysis to determine whether these clusters are enriched in different functions.  
Indeed, these clusters are enriched in highly functionally distinct genes (Table 2.3).  
Cluster I CpG islands are generally associated with genes participating in ‘housekeeping’ 
functions such as transcription and RNA-processing.  In addition, some developmental 
functions, in particular neuron development, are also overrepresented in Cluster I.  
Cluster II CpG islands are associated with genes involved in morphogenesis and cell-cell 
adhesion.  Genes associated with cluster III CpG islands have fewer ontology terms that 
are significantly enriched, which include protein phosphorylation, negative-regulation 
pathways, and signal transduction (Table 2.3).  
 These results are consistent with the idea that hypo-methylation of Cluster I CpG 
islands may regulate housekeeping functions, while variable DNA methylation of 
Clusters II and III may regulate tissue- and developmental stage- specific functions.  We 
further hypothesize that these distinctive functions are likely to be achieved by distinctive 
transcriptional regulation.  Specifically we hypothesize that the cluster I may represent 
generally highly expressed genes across tissues and cells while the clusters II and III 
encode more variably expressed genes.  To test this hypothesis, we examined tissue-
specific transcription of associated genes utilizing recent RNA-seq based gene expression 
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profiles from six distinct human tissues [93].  Tissue specific pattern of expression is 
summarized by the "tissue specificity index" measure (Materials and Methods).  We 
found that genes associated with the cluster I CpG islands are the most broadly expressed 
(tissue specificity is the lowest) compared to those associated with cluster II and III CpG 
islands (Figure 2.8B).  Genes associated with the cluster II exhibit the most tissue-
specific patterns of gene expression (Figure 2.8B). Cluster III CpG islands are associated 
with genes demonstrating intermediate tissue specificity of gene expression compared to 
the other two clusters.  To ascertain that this observation is consistent across large 
number of different types of tissues, we also analyzed the Novartis tissue specific gene 
expression data, encompassing 67 normal tissues [94].  Analyses of these data again 
indicate that the genes associated with the CpG island cluster I are most broadly 
expressed and the genes associated with clusters II and III are associated with narrower 
gene expression patterns (Figures 2.8A,B).  Thus, tissue- specific DNA methylation of 
CpG islands may contribute to tissue- specific expression of associated genes.  
 One way in which CpG islands affect transcriptional regulation is by encoding 
transcription factor binding sites [113].  We examined how often CpG islands overlap 
with transcription factor binding sites conserved in the human/mouse/rat alignment 
(Materials and Methods).  We found that the average number of transcription factor 
binding sites, after normalized by lengths, is significantly higher in CpG islands than in 
the control regions.  Interestingly, the cluster I CpG islands has the largest number of 
TFBSs while the cluster II has the least (Figure 2.8C).  This is consistent with the 
observation that the cluster I is enriched in promoters, while the others are often found in 
intergenic and intragenic regions (Figure 2.6E).  It is also consistent with experimental 
results demonstrating that ubiquitously active promoters harbor large numbers of 
transcription factor binding sites and many CpGs, while promoters that are tissue-specific 
have fewer CpGs [114].  At the same time, even tissue-specific CpG islands appear to 




Figure 2.8. Contrasting expression patterns and transcription factor binding sites of the three CpG island clusters.  Tissue 
specificity gene expression indices based upon RNA-seq (A) and microarray (B) data are shown for the CpG islands genes (blue bars) 









































































Table 2.3. Distinctive functional enrichments of specific genes according to the variable 
DNA methylation of CpG islands.   
GO terms Description  P-values FDR-P-
values* 
 
     
Cluster I CpG islands 
sparse sperm methylation, sparse ESC and somatic cell methylation 
     
GO:0006350 transcription 2.00 X 10
-28
 3.90 X 10
-25
   
GO:0045449 regulation of transcription 3.77 X 10
-27
 7.36 X 10
-24
   
GO:0006396 RNA processing 1.11 X 10
-17
 2.16 X 10
-14
   
GO:0030182 neuron differentiation 2.49 X 10
-15
 4.76 X 10
-12
   
GO:0051252 regulation of RNA metabolic 
process 5.14 X 10
-15




     
 
Cluster II CpG islands 
sparse sperm methylation, variable ESC and somatic cell methylation 
     
GO:0007156 homophilic cell adhesion 1.64 X 10
-9
 3.00 X 10
-6
   
GO:0016339 calcium-dependent cell-cell 
adhesion 9.42 X 10
-9




GO:0007155 cell adhesion 1.83 X 10
-8
 3.35 X 10
-5
   
GO:0022610 biological adhesion 1.98 X 10
-8
 3.62 X 10
-5
   
GO:0048598 embryonic morphogenesis 6.95 X 10
-7
 1.27 X 10
-3
   
     
 
Cluster III CpG islands 
variable methylation in all five methylomes 
GO:0006468 protein amino acid 




GO:0051056 regulation of small GTPase 




GO:0031327 negative regulation of cellular 




GO:0007010 cytoskeleton organization 2.62 X 10
-5
 0.048  
GO:0046578 regulation of Ras protein signal 
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CpG Islands in Disease, Genomic Imprinting, and Aging 
 Having established the CpG island clusters and their distinctive properties at 
genomic, evolutionary and functional levels, we further hypothesized that CpG islands 
with respect to different aspects of human healths and aging may show different 
enrichment over the three clusters. We first asked whether CpG islands in certain clusters 
tend to be over-represented in disease, in particular cancer.  A recent study [115] 
compared DNA methylation maps of over 1,149 tumors of different tissue origins and 
identified genes whose CpG island promoters frequently exhibit aberrant hyper-
methylation in cancers.  Among these promoters that are prone to aberrant hyper-
methylation in cancers, 663 overlapped with our CpG island data.  We find that 649 
(97.8%) of them belonged to cluster I, an extremely significant over-representation (P < 
10
-20
, Fisher’s exact test).  The remaining 14 CpG islands are from the cluster II.  
 We next examined the association between imprinted genes and different CpG 
island clusters.  Imprinted regions are expected to be differentially methylated between 
germline and somatic cells.  To test these hypotheses, we downloaded a list of 
monoallelicly expressed human genes from the genomic imprinting website 
(http://www.geneimprint.org/, Materials and Methods).  Among these imprinted genes, 
33 overlapped with the CpG islands in our data.  Thirteen out of these 33 imprinted genes 
are found in the cluster II, representing a significant enrichment (the expected number of 
imprinted genes in the cluster II is 5, P < 0.05 by Fisher’s exact test; Figure 2.9).  Thus, 
as expected, imprinted genes are over-represented in cluster II which is distinctively 
methylated between germlines and somatic cells.  
 In addition we investigated whether CpG islands that exhibit differential DNA 
methylation with respect to aging tend to be preferentially associated with specific 
clusters.  Recently, whole genome DNA methylation maps of three individuals of 
different ages (newborns, 26 years old, and a centenarian) have become available [116].  
This study has identified 17,930 ‘aging’ differentially methylated regions (DMRs).  The 
 49 
occurrences of 294 CpG islands overlapping with these aging-DMRs in the three clusters 
are shown in Figure 2.9.  While these CpG islands are distributed across all three clusters, 
they are highly significantly over-represented in the cluster II, and significantly under-
represented in the clusters I and III (Figure 2.9). 
   
Figure 2.9. Non-random association between CpG island clusters and distinctive 
biological processes, including gene imprinting (Imprinted), differentially methylation 
region associated with aging (aDMR) and germ line (gDMR).  Significance is assessed 
by Fisher’s exact test: NS P > 0.05; *P < 0.05 ; ** P < 10
-6





 CpG islands are considered as genomic regulatory hotspots.  The advent of 
molecular techniques to examine nucleotide level DNA methylation of all CpG 
dinucleotides in a genome provides an exciting opportunity to investigate detailed 
variation of DNA methylation of these important regulatory regions.  Here we examined 
variation of DNA methylation across multiple methylomes of distinctive origins.  We 
showed that on average CpG islands are highly hypo-methylated, consistent with the 
prevailing idea that CpG islands generally lack DNA methylation [68, 69].  However, we 






























across multiple methylomes (Figure 2.3).  In fact, CpG islands exhibit significantly 
greater degrees of methylation variation than genomic background (Figure 2.3), a 
surprising pattern counter to the general notion that DNA methylation levels of CpG 
islands are stable[117].  CpG islands are also more highly variable than adjacent regions, 
or ‘CpG shores’[101]  in our data (Figure 2.10).  When we examined methylation levels 
of CpG island shores (defined as 2kb upstream of CpG islands), CpG island shores 
exhibited lower variability of DNA methylation compared to CpG islands (Figure 2.10).  
We further examined CpG sites that are ranked at the top 1% of their variability.  These 
sites are highly enriched with those belonging to CpG islands.  Sites classified as CpG 
shores also exhibit significant enrichments in these sites, but not as strikingly as CpG 
islands. However, there are several critical differences between our study and the 
previous studies of CpG shores: it is possible that CpG shores may specifically increase 
methylation variation in cancer cell lines.  In addition, our study does not consider inter-
individual variability, which may be an important source of epigenetic variability.  
However, tissue specific epigenetic patterns such as DNA methylation are conserved 
between distantly related species such as humans and mouse, despite tens of millions of 
years of divergence [118-120].  Thus, tissue specific DNA methylation patterns have 
deeper evolutionary origins than variation due to demographic factors.  Future studies of 
epigenetic variability are necessary to test some of these hypotheses.  
 
Figure 2.10. Comparison of DNA methylation variability of CpG islands and CpG 
island shores. (A) Comparison of mean methylation levels of CpG sites in CpG island 
shores (red bars) versus those in CpG island context (blue bars). (B) Comparison of 
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methylation variation among 5 human tissues of CpG sites, measured by C. V. 
(coefficient of variation), in CpG islands versus those in CpG island shores.  
 
 Based upon methylome-specific DNA methylation patterns, we can identify 
several distinctive groups of CpG islands, or ‘clusters’.  The first cluster of CpG islands 
are hypo-methylated in all five methylomes.  At the genomic level, these CpG islands 
tend to be longer than those in other clusters, and harbor larger numbers of G and C 
nucleotides and CpG dinucleotides than others (Figure 2.6).  They are also found in or 
near genes involved in essential, housekeeping pathways including regulation of 
transcription and RNA processing.  These CpG islands generally maintain their CpG 
contents, and their CpG island status, on an evolutionary timescale by avoiding DNA 
methylation.  Therefore, cluster I CpG islands are closer to the original definition of CpG 
islands.  We refer to them as ‘broad’ CpG island clusters.  
 We also found that some CpG islands are sparsely methylated in sperms, yet 
exhibit variable levels of DNA methylation in other methylomes (Figure 2.4).  We 
tentatively refer to them as ‘germline’ CpG island clusters.  CpG islands in this cluster 
(cluster II in Figure 2.4A) tend to be shorter and harbor fewer G and C nucleotides and 
CpG dinucleotides than those in the cluster I (Figure 2.6).  They are enriched in cell 
adhesion and embryonic morphogenesis functions, and generally exhibit more tissue-
specific transcription profiles compared to those in the cluster I. 
 Finally, we show that approximately one fifth of all CpG islands exhibit some 
degree of DNA methylation in the five methylomes (cluster III in Figure 2.4).  They tend 
to be much shorter than CpG islands in the other two clusters and harbor distinctively 
fewer CpG dinucleotides (Figure 2.6).  The fact that these are generally hyper-methylated 
in the examined methylomes raises the possibility that these regions may not encode 
regulatory potentials of true CpG islands.  However, an appreciable number (a count of 
327) of CpG islands in this cluster exhibit evolutionary signatures of hypo-deamination, 
indicating that these are maintained as CpG islands by avoiding DNA methylation 
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(Figure 2.7).  It is also notable that there are some CpG islands that clearly exhibit tissue-
specific hypo-methylation among this cluster (Figure 3C, sub-cluster IIIb).  These 
observations indicate that at least some of the CpG islands in this cluster likely to harbor 
true regulatory potential.  On the other hand, almost 10% of these CpG islands were even 
classified as ‘pseudo’ CpG islands, which are genomic regions possessing large number 
of CpG dinucleotides by chance (Figure 2.7).  We have used linear discriminant analyses 
and support vector machine (Material and Method) to examine whether we can separate 
these cluster III ‘pseudo’ CpG islands from the rest of CpG islands ('normal' CpG 
islands).  However, these analyses did not indicate the presence of specific genomic 
features of these ‘pseudo’ CpG islands that are heavily methylated in all methylomes.  
Future analyses of DNA methylation variation in larger number of tissues and from 
different developmental stages are necessary to shed light on the functional significance 
of CpG islands that appear hyper-methylated in the currently examined methylomes.  
 We sought to explicitly connect the observed variation of CpG islands at 
epigenomic and functional levels to the underlying evolutionary features.  A recent 
evolutionary analyses classified CpG islands to several groups, namely ‘hypo-
deamination’, ‘biased-gene conversion’ and ‘pseudo’ CpG islands [85].  We examined 
the correspondence between evolutionary classifications and across tissue variability of 
CpG islands.  First, we confirm that many hypo-methylated CpG islands in the cluster I 
correspond to hypo-deamination CpG islands.  Thus for these CpG islands, the 
evolutionary classification and epigenetic classification correspond fairly well.  
Interestingly however, many CpG islands in the ‘germline’ CpG island cluster, which are 
hypo-methylated in sperm, were classified as ‘biased-gene conversion’ CpG islands 
(Figure 2.7C).  This is puzzling; if they do indeed avoid DNA methylation in germlines, 
they should be more enriched in hypo-deamination CpG islands, similar to the CpG 
islands in cluster I.  To resolve this discrepancy, we hypothesize the following two 
mutually non-exclusive possibilities.  First, the sperm methylation patterns may be 
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distinctive from the methylation patterns during other stages of spermatogenesis that are 
more subject to evolutionary dynamics.  Second, the sperm DNA methylation profiles 
may be highly different from those in oogenesis.  
 Currently, whole methylome data for human oocytes are not available.  However, 
data on sperm and oocyte methylation from mice are available.  Specifically, a recent 
study identified 1678 differentially methylated CpG islands between oocyte and sperm in 
mouse [121].  We thus examined how the orthologous CpG islands of these differentially 
methylated mouse CpG islands are distributed among the CpG island clusters.  We found 
that differentially methylated CpG islands between gametes are significantly more 
prevalent in clusters II and III than expected (Fisher's exact test, P < 2 x 10
-16
 for both 
clusters), while they are significantly under-represented in cluster I (Fisher's exact test, P 
< 2 x 10
-16
, Figure 2.9).  These results provide strong support to the hypothesis that the 
evolutionary signatures of hypo-deamination in cluster II and III CpG islands is due to 
differential DNA methylation between sperms and oocytes.  
 The fact that DNA methylation patterns of human CpG islands do not completely 
correspond to the evolutionary classifications (Figure 2.7) provides unique insights into 
the origin and maintenance of CpG islands.  Many CpG islands may have arisen by non-
methylation related mechanisms such as biased gene conversion (BGC) or by chance 
(pseudo islands), but have been co-opted as regulatory hotspots due to the epigenetic 
functional advantage in the current human genome.  This pattern is particularly strong for 
those CpG islands that are variably methylated across different tissues (Figure 2.7). 
 We show that the variation of DNA methylation across individual CpG islands is 
complex.  Importantly, our analyses illustrate that human CpG islands vary substantially 
in several biological levels, from genomic and evolutionary features to epigenomic 
variation, and functional enrichments.  These observations suggest the presence of a 
fundamental diversity underlying regulatory mechanisms of CpG islands.  For example, 
many intragenic and intergenic CpG islands, such as those in the clusters II and III, may 
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encode cryptic promoters and enhancers that function in a highly tissue- and cell type- 
specific manner.  Furthermore, with the new knowledge gained on the variation of DNA 
methylation found among in normal cell types and tissues, we can contrast epigenetic 
variations of clinical interest to those that naturally exist in future studies.  For instance, 
we demonstrated that the majority of cancer-implicated CpG islands are those that belong 
to the cluster I, which stay hypo-methylated in all examined methylomes so far (cluster I 
in Figure 2.4).  This observation suggests that regulatory function of cluster I CpG islands 
is tightly linked to their hypo-methylation, and DNA methylation of these CpG islands is 
likely to be detrimental and particularly disease-prone.  On the other hand, ‘aging’ CpG 
islands show a distinctive distribution across the three clusters: they are significantly 
more enriched in the cluster II, which consist of CpG islands whose methylation levels 
are highly variable in somatic tissues and embryonic stem cells (Figure 2.9).  We 
hypothesize that some of DNA methylation variation observed during the aging process 
may share common molecular mechanisms with tissue-specific methylation variation.  
For example some CpG islands may be more prone to stochastic variation of DNA 
methylation between cell types and with aging.  However, it should be noted that many 
studies of aging DMRs may be confounded by the effect of different cell types present in 
samples: aging studies often use blood samples which contain diverse cell types, each of 
them exhibiting potentially different methylation patterns [122, 123].  These effects, 
particularly the role of immune system related changes of specific cell types on aging-
DMRs [124, 125], need to be clarified in future studies.  
 Our study illustrates that comprehensive epigenetic profiling of distinctive cells 
will be highly useful in understanding regulatory processes of CpG islands, and 
consequently, furthering our knowledge on the role of CpG islands in disease and/or 
aging.  Our findings may also have immediate practical implications.  For example, the 
widely used infinium human methylation chip (‘Illumina 450K chip’) includes 136K 
positions that are annotated as CpG islands.  Compared to the total number of CpG sites 
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within CpG islands in the human genome (approximately 1.8Mbps), this corresponds to 
7.2% of CpG island CpG sites.  If we examine the representation of CpG sites with 
respect to our CpG island clusters, 7.2, 5.8, and 10% of CpG sites belonging to the 
clusters I, II, and III are targeted by this array.  In other words, this array targets 
significantly a higher proportion of CpG islands in the cluster III, which include 
substantial number of ‘pseudo’ CpG islands.  Consequently, some of the epigenomic 
variation detected by these positions may lack true regulatory meanings.  On the other 
hand, given the enrichment of ‘aging’ CpG islands in cluster II, a method targeting more 
positions in the cluster II could be more efficient in identifying aging associated variation 
of CpG islands.  Findings from our study may help in designing better methods to 
examine variation of DNA methylation across different biological conditions.   
 With the positive outlook on whole genome methylation profiling, we expect that 
the number of distinctive human methylomes will increase by an order of magnitude 
within the next few years.  We expect our framework of CpG island diversity at many 
biological levels to be helpful in interpreting such new data.  In turn, these new data will 
allow us to investigate biological diversity of CpG islands more deeply, and answer some 





 Recombination, which involves the exchange of genetic information by the 
pairing of homologous chromosomes during meiosis, is a common biological process in 
diploid eukaryotic organisms [126].  As such, it is a fundamental evolutionary 
mechanism that profoundly affects genomic variation.  For example, more than 50% of 
the variation in nucleotide heterozygosity across the genome is due to recombination in 
flies and humans [127].  Evidence also shows that genomic features such as codon bias, 
nucleotide substitutions and dynamics of repetitive DNA elements are extensively shaped 
by recombination [128-130].  Due to its essential role in reproduction as well as its 
critical importance in genetic analyses, major efforts have been dedicated in constructing 
genome-scale, high-resolution recombination maps [131-133] and developing new 
molecular techniques to analyze recombination patterns [134, 135].  This work has 
substantially furthered our understanding of this important biological phenomenon.  One 
important finding is that the distributions of recombination rates are non-uniform across 
the genomes in many species; recombination events are concentrated in highly localized 
areas known as "hotspots", which in the human genome are typically 1-2kb long and 
surrounded by much longer regions that are essentially devoid of recombination [136-
138].  For example, in the human genome, about 80% of the recombination take place in 
less than 15% of the sequence [139].  Moreover, recombination rates appear to vary 
between individuals, populations and species, indicating that recombination rates can 
rapidly between closely related species, and even within a species [140-142].  For 
example, it is proposed, based upon studies of human recombination hotspots, that 
hotspots can emerge and disappear in as little as 120,000 years, and certainly within the 
six million years since humans diverged from chimpanzees [143].  Such variable and 
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heritable patterns also indicate that recombination may evolve in response to natural 
selection [144, 145].   
 However, the causative factors underlying this variation are largely unknown.  
Previous studies have identified numerous factors, including molecular, environmental 
and demographic factors, that affect recombination rates [146].  At the genomic level, 
recombination rates are significantly associated with several sequence characteristics 
such as GC content, gene density, simple repeats, transposable elements and a number of 
different sequence motifs [147-150].  However, DNA sequence itself does not provide a 
full explanation for variation of recombination rates.  For example, the locations and 
usage of recombination hotspots vary between extremely closely related species such as 
humans and chimpanzees [140], and even among human individuals [151], where the 
underlying sequences are extremely similar.  These observations have thus sparked much 
interest on exploring how epigenetic factors may be involved in determination of 
recombination patterns. 
 As an epigenetic modification known to be established at prophase I in meiosis 
when recombination occurs [152], DNA methylation could be a potential factor affecting 
meiotic recombination rates.  By using methylation-associated single nucleotide 
polymorphisms (mSNPs) as a surrogate marker for germ line DNA methylation, 
Sigurdsson et al. [22] reported a significantly positive correlation between recombination 
rate and DNA methylation.  In addition, Auton et al. [153] reported that promoters that 
have high levels of DNA methylation in human sperms generally exhibit high levels of 
recombination rates.  They also noted that in chimpanzee genomes however the opposite 
pattern was observed (Auton et al. 2012). Other epigenetic modifications, such as histone 
modifications, may also affect the location and activity of recombination events.  For 
example, PRDM9, an important trans-acting factor that controls hotspots specification in 
human, contains a PR/SET domain that is capable of trimethylation of histone 3 lysine 4, 
or H3K4me3 [154].  In mouse genome, H3K4 tri- (H3K4me3) and di-methylation 
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(H3K4me2), which precedes recombination, are enriched at the Psmb9 and Hlx1 hotspots 
[155], and H3K4me3 in yeast is a prominent and pre-existing marks of active 
recombination sites [156].  Together, there is substantial amount of support for the 
hypothesis that epigenetic modifications may affect variation of recombination events.  
However, what are the main epigenetic modification(s) that may underlie variation of 
recombination rates, and how do they affect evolutionary dynamics of recombination 
rates, remain to be resolved.  In this study, we explored the impact of epigenetic 
mechanisms on determining species specific recombination hotspots.  We show that at 
the global level, DNA methylation explains a large amount of variation in recombination 
rates observed in the human genome.  However, DNA methylation levels appear to be a 
weak indicator of fine scale recombination.  On the other hand, specific modifications of 
histone tails stand out to be important molecular features at the recombination hotspots.  
We show an extensive overlap between both the H3K4me3 and H3K27me3 enriched 
regions to the recombination hotspots across the human genome.  Together with the 
elevated recombination rate at the H3K4me3 and H3K27me3 enriched regions, these 
results indicate that histone modifications may play an important role in shaping the 
genomic landscape of meiotic recombination in human genome. 
 
MATERIALS AND METHODS 
Epigenetic Features 
 In order to analyze DNA methylation at the genomic level, whole genome, 
nucleotide-resolution DNA methylation maps (methylomes) generated from prefrontal 
cortex of human brain [157], and from human and chimpanzee sperms [158] were used.  
These methylomes were all generated with next-generation bisulfite sequencing 
technology and have similar number of mapped CpG sites.  To estimate methylation 
levels of specific genomic regions, we calculated the mean fractional methylation value 
for all the mapped cytosines within that region.  For each mapped cytosine, the fractional 
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methylation value was calculated as: total number of "C" reads / (total number of "C" 
reads + total number of "T" reads), following the method in the previous chapters.  We 
also downloaded the human sperm profiles of H3K4me3 and H3K27me3, which were 
generated by the chromatin-immunoprecipitation sequencing method [159].  Enriched 
genomic regions of these two histone modifications relative to input were identified using 
the USeq analysis package (http://useq.sourceforge.net), which entails calculating false 
discovery rates (FDRS) converting from a window binomial p-value. 
 
Sequence Features 
 For information on GC content, CpG normalized content (CpG O/E), and CpG 
dinucleotide count, custom Perl scripts were written to search within the human (NCBI 
36/ HG 18) and chimpanzee (CGSC2.1/panTro2) genome sequence, downloaded from 
the UCSC Genome Browser (http://genome.ucsc.edu).  We calculated the proportion of 
repeats from certain genomic region based upon the rmsk table for the location and 
properties of repeated elements created using the RepeatMasker 
(http://www.repeatmasker.org), which was built on the Repbase database of repeated 
elements.  For the human genetic map and locations of recombination hotspots, the data 
were based upon applied statistical inference methods to genome-wide genetic 
polymorphism data [160], which is the phase II of the International HapMap.  The 
chimpanzee genetic map and recombination hotspots were retrieved from a study using 
similar methods on polymorphism data of 10 Western chimpanzees [153].  A custom Perl 
script was used to calculate the recombination rates in certain genomic regions (e.g. 
recombination hotspots and coldspots).  In order to check the overlap between the 
species-specific recombination hotspots as well as the overlap between the human 
recombination hotspots and histone modification enriched regions, we intersected the 
genomic locations by using the liftOver tool from the UCSC Genome Browser.  Genomic 
control regions were obtained using the following procedures.  We first removed all the 
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recombination hotspots from the whole genome and then for each simulation of the 
control regions, we randomly sampled genomic regions for the number of times equal to 
the species-specific recombination hotspots and with the identical distribution of CpG 
number to the species-specific recombination hotspots.  We repeated the simulation 1 
million times.  Methylation levels and recombination rates of these control regions are 
calculated the same way as recombination hotspots. 
 
Sliding Windows Correlation and Statistical Analysis 
 The genome-wide analyses were done using three different window 
sizes (250kb, 500 kb, and 1000 kb).  For each window size, we divided the genome into 
non-overlapping windows.  Each window was then assigned values according to its 
genetic and epigenetic properties (recombination rate, number of CpG dinucleotides, 
proportion of repeats, GC content, mean fractional methylation level).  Prior to multiple 
linear regression analysis, we first transformed the data to provide a better fit to normal 
distribution using Box–Cox transformation, a form of lognormal transformation. 
Linear regression was then done using regional recombination rate as the response 
variable using a stepwise backward method.   All the statistical analyses were done using 
R package version 2.5.1. 
RESULTS 
Genome-wide analysis of the correlation between DNA methylation and 
recombination  
 In order to test the hypothesis that germline DNA methylation affects rates of 
meiotic recombination, we analyzed the relationship between experimentally determined 
sperm DNA methylation levels and recombination rates in 500kb non-overlapping 
windows across the whole human genome.  As a control, we also performed a similar 
analysis between somatic DNA methylation and recombination using methylation maps 
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from prefrontal cortex of brain (see Materials and Methods).  We observed that 
recombination rate increases roughly linearly with increasing level of DNA methylation 
in sperm at the 500kb genomic windows (Pearson's correlation coefficient = 0.211, P < 
10
-16
; Figure 3.1A).  In contrast, this pattern is not obvious in brain (Figure 3.1B).  
Recombination rate and DNA methylation level are only slightly correlated in brain 
(Pearson's correlation coefficient = 0.03, P = 0.01), indicating that the association of 
DNA methylation and recombination may be unique in germlines.  We also performed a 
genome-wide analysis of correlation between DNA methylation and recombination rate 
in chimpanzees using the same method.  Intriguingly, we found that the trend of the 
correlation in sperm is weak at most, in the opposite direction to what’s observed in the 
human genome (Pearson's correlation coefficient = -0.04, P = 0.002), and no correlation 
at all in chimpanzee brain (Pearson's correlation coefficient = -0.002, P = 0.84).  
 In order to confirm that the observed correlation between DNA methylation and 
recombination rate in human sperm is robust against different window sizes, we 
performed the genome-wide analyses using other two different window sizes (250kb and 
1000kb).  The results show that the significantly positive correlations are present in all 
analyses with different window sizes (Table 3.1).  The correlation coefficients increase 
with increasing window sizes, implying that DNA methylation may influence 
recombination rates in a broad-scale. 
 The observed correlations could be due to other genomic features that influence 
both DNA methylation and recombination rates [147, 148].  Therefore, we performed a 
partial correlation analysis accounting for previously suggested sequence factors 
influencing recombination rate (GC content, repeats) as well as factors correlated with 
DNA methylation (CpG density).  After correcting for these factors, we still found a 
significant and positive correlation between DNA methylation level and recombination 
rate (Pearson's correlation coefficient = 0.199, P < 10
-16
).  We also built a linear model 
where recombination rate was a response variable, and sequence features (GC content, 
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number of CpGs, proportion of repeats) and epigenetic feature (sperm DNA methylation 
level) were predictor variables in the 500kb genomic windows.  We first checked the 
variance inflation factors (VIFs), which are indicators of multi-colinearity among 
variables.  None of the explanatory variables exhibit VIFs greater than 5 (Table 3.2), 
demonstrating that we could assess individual contributions of each genomic trait without 
the influence of multi-colinearity.  We then calculated the standardized coefficients, 
which facilitates an assessment of the strength of association between each predictor 
variable and the response variable.  We found that GC content and proportion of repeats 
in the genome window are the strongest and second strongest predictors for the 
recombination rate (Table 3.2).  Consistent with the partial correlation results, DNA 
methylation is also a strong predictor for recombination rates (Table 3.2).  In total, the 
proportion of recombination rate variability explained by the linear model was 0.324. 
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Table 3.1. Genome-wide analysis of the correlation between DNA methylation and 
recombination rate using different window sizes. 
Window size (kb) R P-value  
250 0.158 < 2.2 X 10
-16
 
500 0.212 < 2.2 X 10
-16
 




Table 3.2. Multiple linear regression of recombination rate as a response to sequence and 
epigenetic feature predictors in 500kb genomic window. 
 Standardized β P-value  VIF 
GC content 0.375 < 2.2 X 10
-16
 3.27 
Proportion of repeats -0.237 < 2.2 X 10
-16
 1.17 
Fractional methylation 0.134 < 2.2 X 10
-16
 1.42 
Number of CpGs -0.044 0.05 3.59 
Adjust R
2
 0.342   
 
Figure 3.1. Recombination rate is positively correlated with DNA methylation level 
in sperm but not in brain. Integrating fraction methylation level with recombination 
rate, we observe a positive correlation between these two factors in sperm (A) but not in 
Brain (B).  The x-axis represents increasing levels of DNA methylation from left to right.  
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DNA methylation and recombination hotspots 
 After identifying positive correlations between germline methylation and broad-
scale recombination rates in the human genome, we continued to explore whether DNA 
methylation is associated with fine-scale recombination patterns.  We investigated 
recombination hotspots, which are usually 1-2kb in length and have significant (usually 
in orders of magnitude) increase in recombination rate from the background [136, 137].  
Based upon the positive correlations between DNA methylation and recombination rate 
in human sperm, it would be expected that the DNA methylation level of recombination 
hotspots should be higher than the genomic background.  Consistent with this prediction, 
we found that DNA methylation levels at the species-specific hotspots are significantly 
higher than the genome average as well as the genomic control regions in the human 
genome (Figure 3.2A).  The genomic control regions have the same CpG number 
distribution of the recombination hotspots (see Materials and Methods).  Interestingly, we 
found the same pattern in the chimpanzee genome.  However, the difference of DNA 
methylation level between recombination hotspots and genomic background is more 
significant in human than in chimpanzee (Figure 3.2A). 
 Several studies have shown that recombination hotspot locations and usage are 
highly divergent between humans and chimpanzees [140, 141, 151].  Considering that 
these two species have highly similar genomes, other factors, such as epigenetic factors, 
may contribute to the evolution of species-specific hotspots.  We also utilized the fact 
that there are small numbers of recombination hotspots that are common between human 
and chimpanzee genomes.  We identified a total of 131 ‘common’ recombination 
hotspots (see Materials and Methods).  The most parsimonious explanation for these 
common hotspots is that they may have existed in the genome of human and chimpanzee 
common ancestor: thus species specific hotspots may be evolutionarily ‘younger’ than 
the common hotspots.  We then compared the variation of recombination rates and DNA 
methylation levels of 1) common recombination hotspots (n = 131), 2) species-specific 
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recombination hotspots (n = 9169 and 4906, for humans and chimpanzees, respectively), 
and 3) the syntenic genomic regions corresponding to the species-specific hotspots of the 
other species (e.g., human genomic regions syntenic to chimpanzee recombination 
hotspots while not recombination hotspots in the human genome: n = 4906, chimpanzee 
genomic regions syntenic to human recombination hotspots while not recombination 
hotspots in the chimpanzee genomes: n = 9169).  The syntenic regions may be considered 
as genomic ‘control’ regions for those recently became recombination hotspots in the 
genome of the other species.  
 We first examined distributions of recombination rates across these three types of 
genomic regions.  As expected, human-specific recombination hotspots have much higher 
recombination rates than the syntenic regions of chimpanzee recombination hotspots 
(Figure 3.2C) and vice versa (Figure 3.2D).  We also observed that species-specific 
recombination hotspots exhibit significantly higher recombination rates than the common 
recombination hotspots in both species (Figure 3.2C, 3.2D).   
 We then compared DNA methylation levels of these three types of genomic 
regions.  Interestingly, the patterns observed here do not follow the genome-wide trend of 
strong correlation between DNA methylation and recombination.  In the human genome,  
syntenic regions of chimpanzee recombination hotspots on average exhibit lower levels 
of DNA methylation than human-specific recombination hotspots, but significantly 
higher than common recombination hotspots (Figure 3.2E).  In the chimpanzee genome, 
syntenic regions of human recombination hotspots are significantly more methylated than 
both the chimpanzee-specific recombination hotspots and common recombination 
hotspots (Figure 3.2F).  Thus, both species exhibit the following pattern of methylation 
gradient: human recombination hotspots (or regions syntenic to human recombination 
hotspots) > chimpanzee recombination hotspots (or regions syntenic to chimpanzee 
recombination hotspots) > common recombination hotspots.  
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 To examine this observation further we performed the following experiment.  We 
calculated inter-species methylation differences between the average fractional 
methylation level at the human-specific recombination hotspots and their syntenic regions 
in chimpanzee, as well as the methylation difference between the chimpanzee-specific 
recombination hotspots and their syntenic regions in human (to facilitate a direct 
comparison, the difference was always calculated as mean methylation level in human - 
mean methylation level in chimpanzee).  In order to take the methylation difference at the 
genomic level between human and chimpanzee into account, we calculated the 
methylation differences by generating the genomic control regions and obtained the 
distribution of the these methylation differences by bootstrapping one million times (see 
Materials and Methods).  If the correlation between DNA methylation and recombination 
is consistent at the recombination hotspots with the genome-wide level, we should 
observe a decreased methylation level difference at the chimpanzee-specific 
recombination hotspots and increased one at the human-specific recombination hotspots 
when compared to the genomic control regions.  However, methylation differences at 
both human- and chimpanzee-specific recombination hotspots do not deviate 
significantly from the distribution of bootstrapped methylation difference (Figure 3.2B).  
Together, these results demonstrate that DNA methylation may have different effects on 
fine scale versus broad scale recombination patterns. 
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Figure 3.2. Comparison of DNA methylation and recombination rates between 
recombination hotspots and syntenic regions. (A) Comparison of average fractional 
DNA methylation level among recombination hotspots, genomic control regions and 
genome background in human and chimpanzee. (B) Distribution of bootstrapped 
methylation difference (always calculated as ‘Human-Chimp’).  The observed inter-
species methylation difference are marked for human-specific recombination hotspots 
(blue arrow) and chimpanzee-specific recombination hotspots (red arrow). Comparison of 
average recombination rate (C) and fractional DNA methylation level (E) among human-
specific recombination hotspots (Human specific), common recombination hotspots 
(Common) and human syntenic regions of chimpanzee-specific hotspots (Syntenic) in 
human genome. Comparison of average recombination rate (D)  and fractional DNA 
methylation level (F) among chimpanzee-specific recombination hotspots (Chimpanzee 
specific), common recombination hotspots (Common) and chimpanzee syntenic regions 
of human-specific hotspots (Syntenic).  For (C), (D), (E) and (F), the average of 
recombination rate or DNA methylation level for the genomic control regions in the 





















































































































































Histone modifications and recombination hotspots 
 The PR domain-containing 9 locus (PRDM9) is an important trans-acting factor 
that controls hotspots specification in both human and mice [154, 161, 162].  This factor 
can specifically binds to a 13-bp consensus motif that is common to many human 
hotspots.  PRDM9 contains a KR protein-protein binding domain [163], a PR/SET 
domain that can trimethylate H3K4 [164] and an array of 8–16 zinc fingers.  It is 
expressed only during early meiosis, and deficiency of the protein results in abnormal 
meiosis with aberrant location of DNA strand breaks [164].  In a detailed study of two 
recombination hotspots in mouse, it was shown that H3K4 trimethylation (H3K4me3) 
precedes recombination and potentiates hotspot activity [155].  Therefore, we 
hypothesize that the H3K4me3 profile in germline may affect recombination patterns, 
especially the location and activity of hotspots.  To investigate whether H3K4me3 is a 
global feature of recombination hotspots, we examined histone modification profiles of 
human sperms.  Human sperm generally lacks histones, as most of histones are replaced 
with protamines during early germ cell development [159].  Nevertheless, we found that 
human specific recombination hotspots exhibit over 3-fold enrichment of H3K4me3 
enriched regions: we found that 816 human recombination hotspots are overlapped with 
H3K4me3 enriched regions (see Materials and Methods), while the expected number of 
overlap is 229 if the H3K4me3 marks were uniformly distributed in the genome (Figure 
3.3).  This is a highly significant enrichment based upon Fisher’s exact test (P < 10
-16
, 
Figure 3.3).  By contrast, neither common recombination hotspots nor syntenic regions to 
chimpanzee recombination hotspots exhibited statistically significant enrichment (Figure 
3.3).   
We also examined the distribution of the H3K27me3 mark at the hotspots.  We 
found that the H3K27me3 mark is also significantly over-represented in the human 
recombination hotspots but not as strongly as the H3K4me3 mark (Figure 3.3).  
Intriguingly, H3K27me3 is also slightly (1.6-fold) but significantly over-represented at 
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the human syntenic region of chimpanzee recombination hotspots (Figure 3.3).  The 
number of H3K27me3 enriched regions is also higher than expected in the common 
recombination hotspots (11 observed compared to 4 expected), but this comparison is not 
significant due to the small sample size.  Moreover, we found that the average fine-scale 
recombination rates around both the H3K4me3 and H3K27me3 enriched region show an 
interesting pattern: we found recombination rates are elevated by about 20% and 25% at 
the H3K4me3 and H3H27me3 enriched regions respectively, when compared to the 
genomic background (Figure 3.4A). 
 
Figure 3.3.Histone modifications are associated with human recombination hotspots. 
Fold enrichment between observed and expected overlapping of H3K4me3 and 
H3K27me3 to human-specific recombination hotspots (Human), common recombination 
hotspots between human and chimpanzee (Common) and human syntenic region of 




 Several technical developments, including computational and statistical analyses 
of single-nucleotide polymorphism (SNP) data, molecular analyses of recombination 
hotspots in sperm samples and large-scale analyses of pedigrees, are propelling current 
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evolutionary processes [165].  Emerging evidence indicates that DNA sequences 
themselves are not the sole determinants of inter- and intra-species variation in 
recombination patterns.  For example, hotspot locations and usage vary among human 
individuals, and between humans and chimpanzees [153, 160].  DNA methylation is a 
strong candidate epigenetic factor that may affect recombination patterns, since it was 
proven to be established at prophase I in meiosis when recombination occurs [152].  In 
this study, we thus examined detailed relationships between DNA methylation levels and 
recombination rates utilizing comprehensive whole genome nucleotide-resolution DNA 
methylation maps from human and chimpanzee sperms and brains.  These nucleotide-
resolution DNA methylation maps allow us to investigate fine-scale variation of DNA 
methylation and correlate with the evolution of recombination hotspots.  We found that 
DNA methylation level is significantly and positively correlated with recombination rate 
in sperm but not in brain.  This indicates that the germline DNA methylation affects 
variation of broad-scale recombination patterns, while somatic DNA methylation patterns 
do not. 
 Sigurdsson et. al [22] have previously explored the co-variation between germline 
DNA methylation and recombination.  Due to the lack of experimentally determined 
DNA methylation data at that time, they used methylation-associated SNPs (mSNPs) 
from HapMap data set as a surrogate marker for germline DNA methylation.  Even 
though the result of this study (referred to as ‘mSNP’ henceforth) also showed a genome-
widely positive correlation between mSNPs and regional recombination rate, there are 
several notable and significant difference between the mSNP study and the current study: 
1) mSNPs were generally higher correlated with recombination rate than our study. For 
example, the correlation coefficient was 0.622 in 500-kb windows from the mSNPs 
study, while it is 0.212 based on the result from our study.  2) mSNPs was found to be the 
strongest predictor of recombination rate in a linear model from the ENCODE regions 
with increased density of known SNPs and sequence information.  But our model 
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indicates that the effect of DNA methylation in recombination rate is weaker than other 
sequence features (Table 3.2).  These two discrepancies can be explained by the idea that 
mSNP density actually not only reflects DNA methylation levels per se, but also other 
sequence features, such as GC contents, CpG dinucleotide contents and repeat 
frequencies.  Our study thus may provide more realistic representation of the genome-
wide relationship between DNA methylation and recombination rates.   
 Unlike the observation in human genome, we found a slightly but significantly 
negative correlation between DNA methylation level and recombination rate in the 
chimpanzee genome.  This result is consistent with the finding of recombination 
elevations at the promoters of genes with high level of DNA methylation in human, but in 
chimpanzee the elevations occur at the genes with low level of DNA methylation [153].  
Therefore, DNA methylation may have species-specific effect in shaping the global 
and/or regional recombination pattern.  Alternatively, it is possible that chimpanzee 
recombination rates data contains more noise than the human data, and the observed 
(weak) negative correlation is spurious.  Analyses of future more refined chimpanzee 
genomic recombination rates variation of recombination rates in chimpanzee genomes are 
necessary to resolve this question.  
 The third and the most significant difference between our study and that of 
Sigurdsson et al.  is the relationship between fine-scale recombination rates and DNA 
methylation.  In Sigurdsson et al. [22], mSNP frequencies were positively correlated with 
the number of bases within recombination hot spots in a genome-wide resolution of 125
–1000 kb, thus the authors claimed that DNA methylation might also affect 
recombination strongly at fine-scale.  However, when we examine experimentally 
determined DNA methylation levels at human- and chimpanzee-specific recombination 
hotspots, we find a very intriguing pattern: while recombination rates show significant 
difference between species-specific recombination hotspots versus syntenic genomic 
regions corresponding to the recombination hotspots in the other species, DNA 
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methylation levels do not (Figure 3.2B, E and F).  This observation implies that 
molecular mechanisms linking recombination and DNA methylation may be divergent 
between fine-scale and broad-scale recombination patterns.   
 To explore this observation further, we utilized the fact that there are ‘common’ 
recombination hotspots shared between human and chimpanzee genomes.  Given that 
recombination hotspots evolve rapidly [141, 142, 160] and that there is no evidence that 
common recombination hotspots independently evolve in human and chimpanzee 
genomes, a parsimonious explanation is that these common hotspots represent those that 
were shared between the two genomes before the evolution of species-specific 
recombination hotspots.  Interestingly, in both species, genomic regions belonging to 
human recombination hotspots exhibit the highest DNA methylation levels, followed by 
chimpanzee-specific recombination hotspots, and the common recombination hotspots 
(Figure 3.2E, 3.2F).  These observations suggest that some sequence characteristics can 
account for the high degree of DNA methylation in both species in spite of the highly 
divergent inter-species recombination rates.  Human recombination hotspots, and 
chimpanzee genomic regions syntenic to human recombination hotspots, may harbor 
specific sequence characteristics that are associated with high DNA methylation.  
Chimpanzee recombination hotspots and human syntenic regions to chimpanzee 
recombination hotspots also carry some sequence signatures for high levels of DNA 
methylation.  On the other hand common recombination hotspots may have lost some of 
these sequence features which lead to the decrease of DNA methylation level.  
 The observed correlation between DNA methylation and recombination rate could 
due to a third variable, such as histone modification that can interact with both variables 
and may be more proximal to the cause.  The PRDM9 locus plays significant roles 
generating recombination hotspots [154, 161, 162].  This protein encodes a SET-
methyltransferase domain in the Prdm9 gene, which is responsible for the trimethylation 
of H3K4 [164].  Mutations in zinc-finger-encoding region of this locus leads to the 
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change of contact residues in the DNA sequences, provide a simple means of replacing 
lost hotspots [166].  We thus investigated the association of the H3K4me3 and 
H3K27me3 to the recombination hotspots using Chip-Seq in human sperm [159].  We 
and found that both of these histone modifications are significantly enriched at the 
human-specific recombination hotspots, but not at the common recombination hotspots 
(Figure 3.3).  This result is consistent with the idea that the PRDM9 play a critical role in 
creating a whole new family of recombination hotspots [166].  This result, together with 
the observation of elevated recombination rates at the H3K4me3 enriched loci (Figure 
3.4A), supports the idea that H3K4me3 may be a global feature at the human 
recombination hotspots, as it was observed in mouse genome [167].  Our observation of 
enriched H3K27me3 mark at the human-specific recombination hotspots is partially 
contradict to the study showing the H3K27me3 is enriched at the Psmb9 hotspot in the 
recombinationally inactive mouse strain [155].  However, the previous study only 
investigated a single recombination hotspot in mouse while our study checked the 
association of H3K27me3 to the human-specific hotspots genome-widely.  In addition, 
there are 10,621 genomic regions bear both H3K4me3 and H3K27me3 marks, thus 
termed bivalent regions, and we found that one third of the overlaps between human-
specific recombination hotspots and the H3K27me3 mark are from the bivalent regions.  
These results indicate that the H3K27me3 mark could also be an important molecular 
feature at the human recombination hotspots and it may affect the recombination pattern 
simultaneously and interactively with the H3K4me3.  This is supported by the 
observation of ~4 fold-enrichment of the association between recombination hotspots and 
the bivalent regions (P < 10
-16
).   
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Figure 3.4. The fine-scale profile of recombination rate at histone modifications and 
their interactions with DNA methylation. (A) Average recombination rate as a function 
of distance to nearest H3K4me3 and H3K27me3 enrich regions. (B) Comparison of DNA 
methylation at the recombination hotspots co-localize with H3K4me3 enriched regions 
alone (H3K4me3), H3K27me3 enriched regions alone (H3K27me3), both H3K4me3 and 


























































 As one of the best studied covalent epigenetic modifications, DNA methylation 
has been investigated in diverse species for the past four decades.  From the studies of 
short individual DNA segments to the high-throughput whole genome analyses, our 
understanding of the function of DNA methylation, especially its relationship to 
transcriptional control, is growing fast.  Even though some generalizations about the 
function role of DNA methylation are holding up, new and unexpected phenomena are 
also being detected all the time, which highlights our limitation in understanding this 
epigenetic system.  The aim of my research was to build an unbiased and comparative 
framework in order to answer several novel and critical questions regarding the 
functional role and evolutionary significance of DNA methylation.  Toward this end, I 
first set out to investigate questions regarding how patterns of DNA methylation differ 
between closely related species and whether such differences contribute to species-
specific phenotypes.  To investigate these questions, we generated nucleotide-resolution, 
whole-genome methylation maps of the prefrontal cortex of multiple humans and 
chimpanzees (methyl-C-seq).  This method is a superior choice for comparative studies 
for a couple of reasons; First, the methyl-C-seq method does not depend on underlying 
sequences, thus making it ideal to be used in comparisons of genome-wide patterns of 
DNA methylation between species. Second, because the methyl-C-seq approach enables 
the methylation frequency of each cytosine to be estimated independently, we can 
evaluate global differences between methylation maps of different tissues and species.  
By using this method, we discovered several significant patterns in the brain methylation 
maps, and inferred potential global-level differences between the brain DNA-methylation 
maps of humans and chimpanzees. Integrating data on DNA methylation with newly 
generated data on gene expression, we show that changes in DNA methylation at least 
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partially explain the divergence of gene-expression patterns in human and chimpanzee 
brains. Furthermore, differentially methylated genes show striking associations with 
specific neurological and psychological disorders and cancers, suggesting that changes of 
DNA methylation might be linked to the evolution of human-specific disease 
vulnerabilities.  In summary, the results of chapter 1 highlight the utility of comparative 
studies in identifying key epigenomic modifications underlying human-specific 
phenotypes, including disease vulnerabilities. 
 In chapter 2, I continued to study the function role of DNA methylation in a 
comparative frameworks and focused on the human CpG islands, which mark epigenetic 
regulatory hotspots of mammalian genomes.  By performing global analyses of DNA 
methylation of CpG islands in the human genome, we examined variation of CpG island 
methylation across multiple methylomes of distinctive cellular origins.  This analysis 
reveals that, contrary to the prevailing notion, CpG islands mark the most highly variably 
methylated regions in the human genome.  Many CpG islands exhibit methylome-specific 
patterns of DNA methylation.  Remarkably, DNA methylation patterns of CpG islands 
reflect their distinctive nature at many biological levels, including genomic 
characteristics such as lengths and nucleotide composition, as well as evolutionary 
features.  Moreover, the regulatory functions of CpG islands are tightly linked to their 
genomic, evolutionary, and DNA methylation features, as evidenced by the co-variation 
between DNA methylation variability and functional ontology terms and transcriptional 
profiles.  In addition, CpG islands implicated in distinctive biological processes such as 
diseases, aging, and imprinting exhibit intriguing differences in their genomic, 
epigenomic and functional features.  These new findings from chapter 2 provide novel 
insights into deciphering the regulatory mechanisms of CpG islands in human health and 
diseases.  What is more important, our results may be used to improve empirical studies 
of DNA methylation variation across different biological conditions and demography. 
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 Finally, as a way to understand the influence of DNA methylation on primates 
genome evolution, we investigated the relationship between germline DNA methylation 
and meiotic recombination, which generates the raw material of evolution and lies at the 
heart of all genetic analysis.  Our genome-wide correlation analyses indicate the positive 
correlation between DNA methylation and recombination rates is present in germline but 
not in somatic tissue such as brain.  Multiple regression analyses suggest that DNA 
methylation might be one additional factor affecting recombination in addition to the 
sequence features.  Intriguingly, we observed that DNA methylation has different effect 
in broad- and fine-scale recombination pattern by comparing both intra- and inter- DNA 
methylation levels at human- and chimpanzee-specific recombination hotspots.  Our 
results also revealed that DNA methylation may closely interact with histone 
modifications to simultaneously regulate the fine-scale recombination pattern.  The work 
in chapter 3 sheds lights on the role of epigenetic mechanisms in explaining the 
phenomenon of inter-individual differences in recombinational activity, despite identical 
DNA sequence, and also highlights the evolutionary significance of DNA methylation in 
the human genome  
 In summary, due to the development of next generation sequencing technique, I 
got the chance to generate and utilize the whole-genome DNA methylation profile, and 
thus provide an unbiased and comprehensive view of DNA methylation pattern in human 
genome as well as in the closely related species, chimpanzee.  The three chapters from 
this dissertations integrate patterns found in genomes, methylomes, and transcriptomes to 
comprehensively analyze the effect of DNA methylation on the regulation of gene 
expression and genome evolution.  By addressing knowledge gaps and longstanding 
questions at DNA methylation in human genome, I hope these work can expand our 
knowledge for this complex epigenetic system, which would finally provide a deeper 
understanding of the much-needed connections between genotypes and phenotypes.  
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